American geologists warn: new york is sinking year by year under the weight of buildings and faces serious flood threat.

Wechat screenshot _20230518104019.png

  New york USA.

  Overseas Network May 18thAccording to the New York Post website reported on May 17, a new geological research report in the United States shows that new york is facing a serious problem of ground subsidence, and the weight of millions of skyscrapers in the city is causing it to sink into the surrounding water.

  According to the research, there are more than one million skyscrapers in new york, which causes the city to sink at the rate of 1-2 mm per year, and the sinking speed is even faster in some areas. Among them, the risk of sinking in lower Manhattan is very serious, and the situation in Brooklyn and Queens is equally worrying.

  Geologist Tom Parsons, chief researcher of USGS, said that the subsidence of the ground made new york extremely vulnerable to natural disasters. Parsons’ team wrote in the research report: "The Atlantic coast of North America faces the threat of rising sea level, and its threat level is three to four times that of the global average; Among them, new york City faces a serious threat of flood disasters, resulting in 8.4 million people facing different degrees of flood hazards. "

  The report also mentioned that new york City has been affected by the ground subsidence since more than ten years ago, and two hurricanes swept through new york in ten years, causing serious damage and casualties. Parsons is worried that many building structures in new york may be eroded by seawater in the future, and said that the probability of high-intensity hurricanes hitting new york will increase in the next few decades. (Overseas Network/Zhang Ni Internship Compilation/Coconut Willow)

China-Central Asia Summit | Kazakhstan experts: The Belt and Road Initiative helps Kazakhstan to diversify its development. There is great potential for cooperation between Kazakhstan and China.

  International Online Report (Reporter Wang Luping): May 18-19, China — The Central Asia Summit was held in Xi ‘an, and it continued to attract global attention. International online reporters interviewed Fatima Kukeyeva, a professor of international relations at Kazakh National University, on topics related to cooperation between China and Central Asian countries. Kukeyeva pointed out that Kazakhstan is the first place to advocate the Belt and Road Initiative, which has made positive contributions to promoting the diversified development of Kazakhstan, and there is great potential for cooperation between Kazakhstan and China.

China — Central Asia Summit | Kazakhstan experts: "One Belt, One Road" initiative helps Kazakhstan's diversified development. There is great potential for cooperation between Kazakhstan and China _fororder_ picture 1

  Fatima Kukeyeva, Professor of International Relations, Kazakh State University

  Kukeyeva said that the Belt and Road Initiative provides an open and inclusive platform for international cooperation and creates favorable conditions for Kazakhstan to integrate into the international transportation chain and industrial supply chain. Since 2013, Kazakhstan has gradually become an important transportation hub in Central Asia. At the same time, the construction and development of the logistics field has also brought convenience to the expansion of cooperation between Kazakhstan and China in the energy field. Various investments and economic and trade cooperation along with the "Belt and Road Initiative" have benefited Kazakhstan’s agriculture, industry, environment, culture and education.

  As a university professor, Kukeyeva is particularly concerned about the achievements and potential of the Belt and Road Initiative in the field of education. She introduced that Kazakh National University has cooperated with more than 30 universities in China to jointly implement scientific research projects and organize expert training. She also specifically mentioned that "experience shows that the educational model adopted by the Shanghai Cooperation Organization University is feasible and effective."

  Kukeyeva praised China for its great contribution to the development of green economy in Kazakhstan. She said that on the one hand, the optimization and adjustment of energy structure is the key to promote Kazakhstan’s economic diversification, on the other hand, the green economy has expanded the space for bilateral energy cooperation between Kazakhstan and China. In 2013, Kazakhstan proposed to transform into a green economy, and planned to increase the proportion of alternative energy and renewable energy in the country’s total power generation to 50% by 2050. In 2017, China released the "Cooperation Plan for Ecological Environment Protection of the Belt and Road", emphasizing the need to build the Belt and Road into a green, prosperous and friendly road, and defining the key tasks of the green Belt and Road construction. Kukeyeva believes that pragmatic cooperation in the field of green energy will play an increasingly important role in Kazakhstan-China friendly exchanges in the future.

  Kukeyeva is willing to join hands with Central Asia to build a closer China for China — The concept of a community of destiny in Central Asia is highly appreciated. She pointed out that this shows that China fully cares for and supports the development of its neighbors while concentrating on its own development and construction. "The concept of promoting the building of a community of human destiny put forward by the Supreme Leader focuses on the common interests and common well-being of all mankind, is committed to building a free and inclusive prosperous world, and contributes wisdom and solutions to promoting the construction of new international relations."

  Kukeyeva said that China and the five Central Asian countries are geographically linked by mountains and rivers, sharing weal and woe in security and complementing each other in economy, which has created broad prospects for cooperation. Today’s international situation is complicated and changeable, and she is very much looking forward to China — The Central Asia Summit will lead all parties to think together about the measures to deal with global risks and challenges. She believes that the summit will provide a more perfect dialogue platform for cooperation and exchanges between China and Central Asian countries, and the results of the summit will further enhance the non-governmental friendship and recognition between China and Central Asian countries, and achieve "common aspiration".

Rational use of antibacterial drugs

1. What are antibacterials, anti-inflammatory drugs and antibiotics?
  Moderator: Good morning, netizens of the Capital Window. This is the interview site of the series of medical ethics Zhao jointly launched by the Beijing Municipal Health Bureau and the Capital Window. Today, we are going to talk to you about the rational use of antibacterial drugs, and we have invited three guests for you:

  Welcome, Yue Xiaolin, Director of Pharmaceutical Machinery Division of Beijing Municipal Health Bureau.

  Yue Xiaolin: Good morning, netizens.

  Moderator: Ma Xiaojun, chief physician of Peking Union Medical College Hospital, director of hospital infection management office and executive deputy director of scientific research department, welcome.

  Ma Xiaojun: Good morning, netizens.

  Moderator: Li Yuzhen, chief pharmacist, professor and director of pharmacy department of Peking University People’s Hospital, welcome.

  Li Yuzhen: Hello, everyone.

  Moderator: Can you tell the netizens about whether antibacterial drugs, anti-inflammatory drugs and antibiotics are the same thing? At the same time, we have a survey result here. One question is whether you usually pay attention to medical and health knowledge. 86.4% people pay attention to medical knowledge. What is the understanding of antibacterial drugs? 40.9% of the respondents thought it was a chemical synthetic drug with strong professionalism. 37.9% of the respondents thought it was an anti-inflammatory drug, and 21.2% thought it was an ordinary bactericidal and bacteriostatic drug, so can you tell us what an antibacterial drug is, and whether it is the same as anti-inflammatory drugs and antibiotics?

  Li Yuzhen: Let me give you a brief introduction. I think the netizen answered very well, but it was not very comprehensive. Antibacterial drugs should include antibiotics from our clinical point of view and scientific point of view, as well as synthetic or semi-synthetic antibacterial drugs. Belong to two categories. According to its production source, antibiotics are produced from the metabolites of microorganisms, animals and plants in some life processes. Antibacterials that are chemically synthesized or semi-synthetic are called synthetic antibiotics, such as quinolones or sulfonamides. We call them synthetic or semi-synthetic. Just now I mentioned some antibiotics from microorganisms, such as penicillin and erythromycin, and tetracycline used a long time ago. Some drugs like this are antibiotics, and antibacterial drugs include these two categories. This is a comprehensive concept.

  Moderator: What about anti-inflammatory drugs?

  Li Yuzhen: The anti-inflammatory drugs that people often say actually refer to antibacterial drugs. The concept of anti-inflammatory drugs we refer to in clinic is completely different, including antipyretic and analgesic drugs and hormones. However, the anti-inflammatory drugs mentioned by ordinary people are antibacterial drugs, which can treat infectious diseases caused by bacteria or mycoplasma, chlamydia and germs, and are called anti-inflammatory drugs by ordinary people.

  Moderator: I can give you such an example. Do you think this understanding is correct? The concept of antibacterial drugs contains the concept of antibiotics, and then, as we usually eat, for example, Baifuning and Fenbid are analgesic, not antibacterial drugs in a strict sense.

  Li Yuzhen: It’s not an antibacterial drug, and it’s totally different from antibacterial drugs. It belongs to antipyretic and analgesic, and it belongs to non-carrier anti-inflammatory drugs.

  Ma Xiaojun: From the different appellations, it is still said that wisdom is among the general public. Because infection will definitely bring inflammation, but inflammation is not necessarily infection. Another clinical point of view, our medical professionals don’t use the name of anti-inflammatory drugs.

  Moderator: Thank you. Let’s tell you a phenomenon. Let’s analyze why. People often say that the more they take anti-inflammatory drugs, the less they care, and they seek doctors to prescribe anti-inflammatory drugs that are more in charge. So everyone asks, does this mean the drug resistance of bacteria? Is this an understanding?

  Ma Xiaojun: Let me try to answer this question. This topic is a topic that the majority of netizens, including the public, are more concerned about. In fact, it can be divided into two aspects: whether the drug is effective or not, whether it is symptomatic, and whether it should be symptomatic but ineffective may be a problem of drug resistance. It doesn’t work either, but both meanings should be included. Let me give you an example. It is rare now, but it used to be an important infectious disease in China, such as meningitis. At that time, the best drug was penicillin, and it is still the same now. Penicillin is very good, very symptomatic and has no drug resistance. But if you use penicillin to treat some negative bacilli infections, such as urinary tract infections, it must be ineffective, because most bacteria are resistant to penicillin. In addition, drug resistance also includes the gradual emergence of antibiotic selective resistance during treatment, which leads to treatment failure, so treatment failure is not necessarily drug resistance, but may be symptomatic.

  Second, how to use antibiotics rationally?

  1. What do patients know about antibiotics?

  Moderator: In your daily diagnosis and treatment, as far as you know, what do our patients know about this kind of drug resistance, including antibiotics and antibacterial drugs?

  Ma Xiaojun: The first thing I contact with in the outpatient clinic is to seek medical treatment, not to diagnose. In the case of definite or ambiguous diagnosis, an experienced infectious doctor can’t wait, and should give him a definite treatment in a relatively early time. This treatment is called empirical treatment before we get the corresponding pathogenic microorganisms, which is very important in our daily clinical practice, even the most important and most clinical prescription behavior. Most of the patients I met in the outpatient clinic didn’t come to prescribe drugs directly. They had a fever or diarrhea or a clear infection in other places. Let’s diagnose them first. In this case, doctors recommend antibacterial drugs or anti-infective drugs, which is usually the mode. However, after some patients come to the clinic, you prescribe a drug, and he will ask a lot about the adverse reactions of special drugs, and when they will take effect, he will pay attention. But after all, drugs are very professional, and medical professionals have more detailed information, so he is more concerned about the efficacy and adverse reactions.

  Moderator: One of the options set in the survey is which of the following do you think should be followed in the rational use of antibacterial drugs? 75.8% people think they are familiar with the indications, antibacterial activity, pharmacokinetics and adverse reactions of selected drugs. 72.7% people think that drugs should be used rationally according to physiological, pathological and immune conditions. 63.6% people think that the appropriate dosage, dosage and course of treatment should be chosen. 56.1% people think that the etiological diagnosis of infectious diseases should be established as soon as possible. I would like to ask the guests how they feel about the results of this survey, and what is the public’s opinion on the preference of the options?

  Li Yuzhen: I think these options are quite comprehensive. If they are all included, the rational use of antibiotics has basically been achieved. To sum up, the rational use of antibiotics mainly considers three aspects. One must first consider the patient’s condition, what kind of infection he has, and this drug should be symptomatic. Second, we should consider the characteristics of the drug itself, that is, the pharmacokinetics, efficacy and safety, that is, adverse reactions and effectiveness that netizens just answered. The third is to consider the patient’s own condition, such as poor liver and kidney or other immune diseases. At the same time, drug resistance, for example, we always think that drugs are effective for this bacterium, but because of the long time of use, drug resistance occurs, so we should pay special attention to the selection of indications at this time. The items that netizens answered just now are scattered choices. In fact, when we consider the rational use of antibiotics, we should consider all of them, not just one of them.

  2. Is it necessary to diagnose the etiology in clinic?

  Moderator: 56.1% of netizens mentioned the patient’s diagnosis, and your introduction, and some of his experience in the diagnosis and treatment process. Do we have any regulations now? Do doctors have to make etiological diagnosis? Because I understand that the diagnosis of pathogens has a process, for example, sputum has a seven-day process, and patients may not be able to wait for seven days. On the one hand, from the perspective of the Municipal Health Bureau, on the other hand, as a clinical doctor, they encounter it in the diagnosis and treatment practice.

  Yue Xiaolin: In fact, we have been emphasizing that all qualified medical institutions should build corresponding laboratories to meet the requirements of culture and drug sensitivity experiments. Therefore, special indicators have also been set up in the special rectification activities of antibiotics, and patients with certain infections should be trained accordingly and get certain results. This has several advantages. The first is to guide clinical medication. I got sick a few days later and got better after taking the corresponding antibiotics, but there is also a possibility that it is ineffective. We have to determine and guide clinicians through the results of sputum and blood, and how to use more effective antibiotics better. Secondly, we can get some epidemiological results by doing experiments and screening out the results. What strains are most infected recently, which drugs are sensitive to these strains and which drugs are resistant to these strains? We will guide clinicians to give more scientific guidance when choosing drugs when dealing with influenza or related diseases this season, which is also of clinical significance.

  Ma Xiaojun: In fact, we always face such a contradiction in clinic. First, netizens are very high-level and put forward very high expectations for us, but whether this expectation is realistic in clinic, we can give an example. For example, a very serious infected patient, accompanied by his family, has severe fever, headache, nausea and vomiting. From our experience, it is basically diagnosed as a central nervous system infection at the first time. In this case, is it possible for the doctor to make such a choice and advise the patient? You haven’t made a definite diagnosis yet, but I think you are like a central infection. Since there is no definite result of pathogenic microorganisms, I won’t treat you first. All microorganisms have a period of growth, which can only be recognized by us after a certain period of time. Can we wait for this period of time? Sometimes we can’t wait. I’ll give you a data. In some seriously infected patients, the survival rate of patients will be reduced by eight percentage points for every hour of delay in correct treatment. So if we wait for an important patient for six hours, the survival rate of this patient will be less than 50%. Together with the process of my treatment, this patient basically has no room for treatment. What should we do? Just now, Yuechu emphasized that we have some good technical specifications. I have a data that is particularly interesting. I participated in the compilation of data in the previous stage. I checked the documents in the United States. Almost all the guidelines I can read in the United States for simple urinary tract infection do not recommend you to do urine test and bacterial culture.This may be strange to everyone, why Americans don’t recommend you to do routine urine culture in such an important infection, especially for young women. Because most studies have proved that most of this type of infection is caused by Escherichia coli, I can treat you without doing it, but if it doesn’t work after three to five days, you should do an appropriate bacterial analysis of the etiology at this time. Therefore, in view of the background of medical reform, it may be necessary to gradually move towards a very scientific medical norm that balances health economics, because after all, we are a developing country. Therefore, doctors are needed for pathogen diagnosis. What should we do? Experience treatment, is the doctor patting the forehead? Director Li is a very experienced expert. Director Li looks well, and I am young. Am I in a fog? In fact, we all follow a basic principle, which is based on past, past and similar patients’ sensitivity when they are infected. On the basis of such a large amount of past experience, we take an empirical treatment model recognized by everyone. Therefore, empirical treatment is not blind, but is actually the result of a larger survey.

  Moderator: There is a better balance and rationality.

  Ma Xiaojun: There is another big problem. The bacteria we find are not necessarily pathogenic bacteria. For example, it is not normal to find bacteria in sputum and urine. The more extreme example is that there must be bacteria in stool. Everyone knows this. Therefore, some of the bacteria we found may be meaningless and need doctors to judge. However, the specimens of sterile parts, such as blood and cerebrospinal fluid, including tissue culture and so on, are really important to find in these places. Therefore, in the professional field, we also appeal, and also use this platform to appeal to the majority of netizens not to worry too much. When doctors suggest that you do some even invasive tests, it is very important to help, especially when the infection is serious. Have a good cooperation with the doctor.

  3. Are anti-inflammatory drugs prescription drugs? Can they be bought in pharmacies?

  Moderator: Here, I will access the questions of several netizens first. Some netizens asked, are anti-inflammatory drugs prescription drugs, and can they usually be bought in pharmacies? This is also a common problem we usually have?

  Yue Xiaolin: Anti-inflammatory drugs are prescription drugs. Let me explain again that anti-inflammatory drugs are commonly known. For example, antipyretic and analgesic products are OTC products and can be bought directly in pharmacies, so what we are talking about is generally within the scope of antibacterial drugs and antibiotics. These drugs are basically prescription drugs and can only be bought in pharmacies with a doctor’s prescription. Of course, the Baifuning you mentioned just now are antipyretic and analgesic drugs, and most of the products are listed as over-the-counter drugs. People can buy related products in pharmacies with their own experience in drug therapy.

  4. What problems should be paid attention to in antibacterial drugs used by infants?

  Moderator: It seems that it will take a long time to reverse everyone’s change of heart. It is still very difficult to completely change it within at least one hour. It is necessary to constantly popularize knowledge, let everyone know what is going on, and put this concept into the hearts of the people. The netizen asked, what problems should be paid attention to in antibacterial drugs used by infants?

  Ma Xiaojun: I’m an infectious disease doctor. I’m supposed to be a general practitioner, but because of the professional development, we do more in adult infection. But in fact, the anti-infection model of adults is not necessarily unavailable in children, but some drugs are definitely unavailable in pediatrics. For example, children under the age of 16 cannot use quinolones, which we all know very well. The treatment ideas and modes of diagnosis are exactly the same. One thing I want to emphasize with you is that although the infection of infants and young children is the same part as that of adults, for example, they are all central infections, but their immune mechanisms are different. When the immunity is different, the pathogenic microorganisms that may be infected are different. Therefore, the initial empirical treatment scheme for children’s infection is very different from that of adults. Therefore, this matter has the special infection characteristics of children of special age. In addition, most of the treatment modes, including the operation of dealing with similar infections, are the same, such as blood culture and corresponding specimens, but the child’s body is relatively small. If there are some special infections in the body, the blood drawn is actually much less than that of adults, which may meet our needs. There is no big difference in the principle.

  Moderator: I saw the parents’ empirical therapy, especially at home. He didn’t go to the hospital. He thought it would be enough for adults to give their children half or a quarter of the medicine.

  Li Yuzhen: Yes, I especially agree with what the host said. I quite agree with what Director Ma said just now, and it was also very good, from a clinical point of view. But I especially want to emphasize that infants and young children should pay special attention to the dosage of drugs. Parents are particularly nervous when they see their children have a fever, so they want to use some anti-inflammatory drugs at home to bring it down, but many fevers are not caused by infection or bacteria, and many are viruses, such as cold virus or influenza. So using some antibiotics is ineffective and should not be abused. Therefore, it is not advisable to use anti-infective drugs on your own and give them to children casually, so you should go to a regular hospital, consult the pediatrics, and use the drugs correctly after a correct diagnosis. In particular, I want to emphasize the dosage of children. Most of the drugs we produce now are not specially used for pediatrics, but the dosage of adults is halved. We hope to read the instructions carefully and be very careful. How old are you? We should pay special attention to this. Sometimes it is wrong, or adults love children. We also heard such a case. In order to give the child medicine, for example, some eye drops, the child was particularly uncomfortable when she ordered this eye drop. I ordered a drop myself first, and the result was very serious consequences, glaucoma, which she didn’t know. So I think we should use medicine carefully, and don’t think that medicine doesn’t matter, as if we had eaten it in the past or something. The expiration date of antibiotics is also very important. I can’t think that I have taken them all in the past.Don’t look at the expiration date, and the storage conditions are very important. Sometimes it needs to be protected from light, refrigerated, and can’t be mixed. It needs special attention. Don’t give antibiotics to children at will.

  Moderator: Let’s look at this netizen’s question. He said that infants have upper respiratory tract infections and doctors have prescribed anti-inflammatory drugs, such as cephalosporins. Will there be any adverse reactions?

  Ma Xiaojun: I think this topic is very representative, but I don’t know the medicine prescribed by the doctor on the first day of the course of the upper respiratory tract infection he mentioned. Let me give you an example, not to say that we should call on everyone to abuse antibacterial drugs, but one indisputable fact is very clear. In our current situation, as an infectious disease doctor, I have seen infectious diseases for many years, and rarely encounter rheumatic heart disease and rheumatic glomerulonephritis. Why are these two diseases reduced? The most important source of these two diseases is the upper respiratory tract infection of streptococcus and rheumatic fever after three or four weeks. Why are there so few such diseases now? In fact, a large part of the reason is that in the early stage of streptococcus infection, the doctor gave him drugs. So there is no absolute bad thing, and there is no absolute good thing. What is the key question? This netizen I suggested that he listen to the doctor’s advice. The doctor prescribed the medicine after consideration. Since it is prescribed, I think it must be reasonable, so I suggested that he accept the doctor’s treatment.

  Third, what are the norms for doctors to use antibacterial drugs in practice?

  1. What is specified in the Administrative Measures for Clinical Use of Antibiotics?

  Moderator: We have been emphasizing following the doctor’s advice. We trust the doctor so much. The prescription prescribed by the doctor includes the doctor’s diagnosis and treatment behavior. His standardization may be a problem that all patients, including their families, are more concerned about. So here I want to ask Yuechu, what kind of norms does Beijing have from the perspective of the municipal government for doctors to prescribe antibacterial drugs?

  Yue Xiaolin: Actually, we have been paying attention to the doctor’s diagnosis and treatment behavior, especially the doctor’s rational drug use behavior for a long time. Therefore, we have relevant laws and regulations to regulate this behavior from several systems. First, from the perspective of laws and regulations, the Ministry of Health has a "Administrative Measures for Clinical Use of Antibiotics", which is already in the stage of soliciting opinions and may be issued in the form of departmental regulations in the near future. This is also a landmark document, which includes the management of clinical rational drug use in the overall management of laws and regulations, indicating the importance attached by the government to this work. Secondly, from the perspective of hospital management. For example, this special rectification of antibacterial drugs does not only emphasize the completion and establishment of the index system, but requires all medical institutions to make important reforms or refined management from the system management mechanism to improve the level of rational drug use by doctors. For example, the importance of the administrative department, the construction of some supporting technical support I just introduced, such as the construction of some clinical laboratories, some necessary clinical laboratories and pathological laboratories, as well as the standardized training of doctors, the special training of antibacterial drugs, clinical guidance, and the follow-up prescription review. For every prescription issued by a doctor who has the right to prescribe antibiotics, we need a clinical pharmacist, and the clinicians handed down from generation to generation organize prescription review in the hospital, which has a certain period. The system construction of these things is to improve the doctor’s medication level from the internal management of the hospital and increase the doctor’s rational medication level. Of course, we are here today,It is also an education of basic medical knowledge for the public. This is all in all aspects. With the cooperation of the government, medical institutions and the public, we take antibiotics at home without authorization, because antibiotics are classified as prescription drugs and can only be used reasonably under the guidance of doctors. Therefore, the government, medical institutions, including the public, cooperate with each other to gradually put the level of rational use of antibacterial drugs in a scientific perspective.

  2. How do hospitals determine the list of antibacterial drugs in our hospital?

  Moderator: I checked some related documents on the Internet, and one of them said that according to the work arrangement of the Municipal Health Bureau, hospitals will comprehensively sort out the list of antibacterial drugs in our hospital according to the control indicators before the end of June, and repel the antibacterial drugs with potential safety hazards, uncertain curative effect, poor cost performance and illegal promotion. According to such relevant regulations, can we have such understandings? Does the first one mean that these retired antibacterial drugs can no longer be purchased in hospitals in the future? Second, are the varieties of antibacterial drugs kept by all hospitals the same, or do all hospitals have their own choices? In addition, does our Municipal Health Bureau also need a dynamic monitoring for these remaining varieties, for example, with the improvement of drug resistance, do we also make some dynamic adjustments?

  Yue Xiaolin: First of all, the establishment of this indicator has gone through a process of scientific argumentation, and Professor Ma also participated in the process of argumentation. First of all, correct a possible misunderstanding. The whole selection process is organized by medical institutions to organize their own pharmacists, managers and clinicians. According to their own whole diagnosis and treatment tasks, for example, we have some specialized hospitals, comprehensive hospitals, secondary and more basic health institutions. When all drugs are required to enter the hospital, they must be demonstrated by the Pharmaceutical Affairs Management Committee before they can enter the drug use list of this hospital. Our clinical pharmacists will consider pharmacology, toxicology, adverse reactions, including cost-effective factors, and give some reference from the perspective of pharmacoeconomics. Clinicians in various departments, such as infectious diseases and surgery-related departments, will also put forward his drug demand. After demonstration, each hospital selected 50 drugs with common names for its drug list. However, the drug list of each hospital is different because of the different tasks undertaken. For example, infection is the main factor, and there may be some specialized departments, so the drugs selected by each hospital can be different. You mentioned it very well just now, and now we have established a dynamic monitoring system, which of course has a lot of technical support. For example, there is a bacterial resistance network, and 50 medical institutions are selected to submit some results of clinical experiments and the basic situation of drug-resistant bacteria to this network. We have a regular information feedback to guide clinical medication.Secondly, all drugs are purchased through the government’s online platform, and the information of drug use in various medical institutions is dynamically monitored from the government’s point of view. Specifically, it will arrive on June 30th, and the People’s Hospital is also doing these things. What we emphasize is to get rid of some drugs that are not suitable for clinical use and prevent drug abuse. This is our goal.

  Li Yuzhen: According to the guiding principles and plans of the clinical management of antibiotics of the Ministry of Health, all our hospitals have actually done their work, and the Beijing Municipal Health Bureau has also attached great importance to it and set a timetable. This timetable calls for the selection of 50 antibiotics by the end of June. I quite agree with some principles mentioned by Director Yue. When selecting, we should first consider the safety of this drug, its economy, effectiveness and drug resistance in our hospital. For example, if you are completely 70% resistant to some bacteria, such drugs should definitely be withdrawn. There are some similar drugs, because there are many manufacturers of the same drug in our country, so we will choose the one with the best quality and the best cost performance to stay. There are many ways and means in the selection process. First, according to the guiding principles of antibacterial drugs in the country, a management team is set up. Under the guidance of our Pharmaceutical Administration and Drug Treatment Committee, the management team is composed of experts from infectious diseases, respiratory diseases, medical services and pharmacy. It is also necessary to formulate the principles of selection, which are also based on the requirements of the Ministry of Health, such as the clinical use of drugs. I quite agree with Yue Chu that the 50 varieties selected by each family are different, because they undertake different tasks. For example, the blood in our hospital is famous, and the infection in hematology department is critical, because after bone marrow transplantation, the immune function declines, and some immune drugs are needed, so the infection is heavier, so some advanced antibiotics,In the third and fourth generations, very effective anti-infective drugs were carefully selected. These 50 kinds, the people think it will not be enough, the original so many, some can not buy. In fact, before we sorted it out, there were more than 50 kinds. After selection, 50 kinds should meet the clinical needs. There is also a document of the Ministry of Health that allows you to make one-time purchases for some special needs. It is entirely from a clinical point of view. From the interests of patients, it is not impossible to use more than 50 kinds across the board, but you have to apply for approval and put on record. There are such regulations.

  Ma Xiaojun: We need to take a look at the current management of antibiotics or the requirements for rational drug use. What’s the purpose? Our purpose is definitely not to remove antibiotics from our medical institutions. The problem we have to solve is that the drug resistance of bacteria is becoming more and more rampant. I think a topic that netizens should pay attention to is that even if antibiotics are used reasonably, the drug resistance of bacteria will definitely increase. This is certain, and this is the first thing to pay attention to. The second thing to pay attention to is my subjective speculation that although the requirements of medical institutions above the second level are different, the differences in the final selected varieties will not exceed 25%. About 70% of them are the same. With different characteristics and different tasks, there may be some emphasis. Because, after all, globally, if China compares with foreign data, we find that the common infections are in these parts, such as respiratory tract, urinary tract, digestive tract and surgical site, which are commonly used medicines. There is also a "Guiding Principles of Antibiotic Drugs" in the Ministry. Such a programmatic document provides technical guidance, so netizens don’t have to be too nervous about whether there will be many drugs. Please rest assured that effective drugs can’t get out. Another director, Li, said that we have an effective regulation, which reflects the requirements of Scientific Outlook on Development. If a drug is temporarily purchased for more than five times, it will be discussed in this hospital whether it will become a routine drug preparation in this hospital in the future. This is a very scientific management norm from the policy point of view.

  Moderator: Now many things are in line with a dynamic adjustment according to the situation at that time.

  Ma Xiaojun: I would also like to add that we have to deal with drug resistance. China has discovered that it is a serious problem all over the world. Therefore, the World Health Organization will set off a World Health Day. The theme of this year is that no action will be taken, and no medicine will be available in the future. This is a topic facing the whole world.

  3. Will the abuse of antibiotics lead to the consequences of no medicine in the future?

  Moderator: Now some people are talking about superbugs, saying that their appearance is to retaliate against the consequences of human abuse of antibacterial drugs. If you don’t take action, there will really be no drugs available, right? Is it really revenge for people abusing antibacterial drugs?

  Li Yuzhen: I think so. Director Ma put it very well. Even if we use antibiotics rationally, its resistance will inevitably occur. The fate of all antibiotics is from research and development to drug resistance to final elimination, which may go through such a process, either clinically or in the life cycle. However, the speed of drug resistance is closely related to our rational use and abuse. Because in the process of using antibacterial drugs, if they come into contact with bacteria for a long time, bacteria will constantly evolve themselves in order to survive, so it is natural to produce drug resistance. Sometimes, you don’t aim at bacteria, but you use a lot of broad and powerful antibacterial drugs, killing the normal flora of the body and slowly growing the pathogenic bacteria, so that drug resistance occurs very quickly. This superbug was discovered in Britain at that time, but its source was found in India and Pakistan, that is, its source was from this country where the management of antibiotics was not very strict. There are similar problems in our country, so the problem of antibiotic resistance is not a local problem, but a global problem. Therefore, the theme of the World Health Organization on April 7 this year is to resist antibiotics. If no action is taken today, there will be no drugs available tomorrow. Therefore, the problem of drug resistance is indeed very serious, and it is also a punishment for us. We should wake up our own medication behavior. As for no medicine available, because it takes a long period for us to develop a new drug, we can develop new antibiotics to deal with drug-resistant bacteria, but the period is very long.No bacteria grow fast in drug resistance, so we really need to be alert to our behavior and protect our environment ourselves, which is actually to protect our own interests. This drug resistance is not only a rational application in hospitals, but also an understanding with others in the society. There are also too many antibiotics used in agriculture and animal husbandry, so many fish, chickens and pigs are also using antibiotics. After eating some things left in their own bodies, we humans will also have some drug resistance. About 40% of antibacterial drugs used in our country are used in agriculture and animal husbandry, so the whole society should work together to rationally use antibacterial drugs and reduce their drug resistance.

  4. Is there a long-term mechanism for bacterial resistance detection?

  Moderator: Just now, several experts said that the speed of developing new drugs can’t keep up with the speed of bacterial resistance, but from the perspective of government supervision, do we have a testing center for bacterial resistance spectrum, for example, which is transmitted to our terminal through the Internet of Things, and even this terminal is not only connected to Beijing, but also to the whole country and even the whole world? Are we still in the process of continuous improvement?

  Yue Xiaolin: I just told you that because the use and resistance of antibiotics is a professional subject, we need professional technical support to help us solve the problem of rational use of doctors and the whole society. The Ministry of Health attaches great importance to this work, including the Beijing Municipal Health Bureau. First of all, you mentioned the first question. There is a relatively large bacterial resistance monitoring network in China. Beijing has also set up a bacterial resistance monitoring network in Beijing on the basis of the national drug resistance network since the whole year. We have absorbed some tertiary hospitals and some secondary hospitals, because now the secondary institutions have also received many patients in infectious diseases, and we will get some regular things from the whole results to guide drug use. At present, more than 50 hospitals have been included in the scope of our bacterial resistance monitoring network. Through the construction of the basic network and the central network, relevant data, including some strains, have been submitted to the central network, and we also regularly feed back information to medical institutions. There is only one goal, to guide the rational use of antibiotics in clinic through scientific results, to reduce the emergence of drug resistance cycle in antibiotic resistance time, and to make the whole country mention that the future drugs should be used effectively and the health level should be well controlled and improved.

  Moderator: Do you think it is necessary to let the public know about our drug resistance to bacteria and its data monitoring?

  Ma Xiaojun: I think it depends on how you understand it. The same data may be interpreted differently by different groups. For example, it is said that cephalosporins are highly resistant to a certain drug, and some patients will ask why they are prescribed to me after being so resistant. But it is the best choice for another kind of germs. So how do we understand antibiotics and how to understand drug resistance is a topic in a professional field. We are not only the Health Bureau, the Ministry of Health, but also the national monitoring network. As an infectious disease doctor, I understand this very well, but it is a trend thing. He tells us what the general trend is and what the drug resistance is. But from the public point of view, this is not the whole country, nor is it the whole of Beijing. For example, the most serious problem facing China now is not the drug resistance of positive cocci, but the drug resistance of negative bacilli. On the contrary, in the United States, the drug resistance of down-peptide-resistant cocci in the United States is very serious, and this is less than 5% in China, which shows that our trend-oriented things have regional characteristics, so if the trend is concerned, the monitoring network is very important, and in terms of treatment, every treatment is a case, so from this perspective, For the dissemination of drug resistance information, we can let more professionals know in the professional field. In the public field, I personally feel that the evaluation of antibiotics is a very good tool for our human self-salvation, and everyone should protect it from different angles.

  Fourth, netizens ask questions

  1. To what extent do you need to use antibiotics when you have a cold?

  Moderator: Next, I will pay attention to a few questions of netizens. The netizen asked, to what extent do you need to use antibacterial drugs when you have a cold?

  Ma Xiaojun: Let’s talk about this separately. For example, the infection of streptococcus just now started with sore throat. Maybe his symptoms will be a little bit, or even early viral infection, because viral infection may weaken our local defense ability, followed by bacterial infection, so to what extent, I’m afraid it’s difficult to give a standard. For example, antibacterial drugs are needed for a fever of 39 degrees. This is not so divided. I suggest that if necessary, you go to the hospital for a simple check-up, such as a blood routine, and look at some other laboratory indicators to roughly distinguish between bacteria and viruses. Even if you don’t treat viral diseases, you can alleviate them through symptomatic treatment for three to five days, such as drinking water and taking antipyretics.

  Moderator: I also heard a saying that it is viral. Is this cold a further improvement of the autoimmune system?

  Ma Xiaojun: I can’t understand it this way. Whether we will get infected depends not only on viruses or bacteria, but also on one aspect. My own ability is another aspect. In our field of infection, I will talk about three topics, one is the number of bacteria that we have been exposed to in a single time, the other is what the independence of this bacteria or pathogenic microorganisms is, and what the human immunity is at this moment. Now, when the virus hits human beings, it is often not an improvement, but a weakening. If there is a fever and infection that you can’t stand, for example, you must go to the hospital for treatment. For example, if you have a temperature of 37 degrees or 38 degrees, you can take antipyretics, so you can take some OTC medicine at home, but if you have a fever for a long time, you have to go to the hospital.

  2, cardiovascular and cerebrovascular, hypertension patients need to pay attention to what problems in daily use of antibacterial drugs?

  Moderator: netizens asked what problems should be paid attention to when patients with cardiovascular and cerebrovascular diseases and hypertension use antibiotics daily?

  Li Yuzhen: This problem involves the drug interaction between patients suffering from multiple diseases and taking multiple diseases, which must be paid attention to. Just mentioned cardiovascular and cerebrovascular diseases, hypertension and other diseases, there are many kinds of drugs used, and there are also many anti-infective drugs, so the specific problems should be analyzed in detail. For example, this patient has a lot of blood lipids, but he has respiratory infection. At the same time, he uses some drugs such as erythromycin and simvastatin. When using them together, he should pay special attention, because they are all metabolized in the liver, and they all have to compete with the drug enzymes of the liver. If they are taking such a drug, it may cause the concentration of statins to increase, which may easily lead to statins being very safe drugs at ordinary times, but because they cannot be metabolized in the body, the concentration in the body increases. It may cause liver damage or muscle pain, and such adverse reactions will come out, so special attention should be paid to the interaction of drugs. When anti-infective drugs are combined with other drugs, specific problems should be analyzed, and the instructions should be read carefully. It is not possible to say in general that you can’t use this drug after using other drugs, or you can use two of them casually. I think it is necessary to pay special attention.

  3. Is there an inquiry channel for the specific dosage for indications of various antibacterial drugs?

  Moderator: In our survey, netizens also want to know the solution of drug resistance, including adverse reactions, including how to use them correctly. Some netizens said that it would be best if the specific dosage for indications of various antibacterial drugs could be found online. Is this netizen’s suggestion operable or necessary?

  Ma Xiaojun: This is no longer a problem. Now he can find interesting questions in some search engines. The question I gave this netizen is what you can do after you know this information. After all, you are not a doctor. This topic is very good, that is, we should pay attention to self-health or self-treatment. But let me give you an example. You will see a very interesting detail in the media. I don’t say that foreign products are good. Many foreign patients are like this. The doctor gives him medicine and he doesn’t even know what the medicine is called. I’m surprised. They said the medicine prescribed by the doctor was edible. But he is concerned that if he has any problems after eating, he will communicate with the doctor. So from this point of view, I suggest that you can understand, but after all, medication is a very professional topic, which is not an ordinary thing. I have seen a very extreme example. I took a very simple medicine and died of explosive liver necrosis, so I can understand the medicine, but it may not be necessary to communicate with doctors too much, so it is better for everyone to live a relatively simple life.

  Moderator: This shows that foreign countries trust his doctor very much. The second point is that he doesn’t need much knowledge, but after taking it, he will pay attention to his health. This is also a problem that our health and patients, including myself, should think about, because sometimes when I get the medicine, I will study it online first. In fact, at present, our clinic time and the doctor’s clinic time don’t have much time to discuss such a topic.

  Ma Xiaojun: In the information we get online, even if the incidence is one in ten thousand, as long as the research finds it, we should write it in. However, there is nothing for the patient, and you just have an adverse event that is not in the manual. Because it is a very small probability, it has occurred, so how can we balance this problem? Still, as a doctor, I suggest that the majority of netizens should be able to see a doctor. This is a science.

  4. Is it necessary to take antibacterial drugs for diarrhea and dermatitis?

  Moderator: Next, let’s look at such a question. There are two diseases in summer, one is diarrhea and the other is dermatitis. At this time, everyone will take some medicine by themselves, but I want to ask if it is necessary to take antibacterial drugs for diarrhea. Including dermatitis, because I sometimes have allergies, and I use an ointment called Elozon. Should I not be a doctor myself?

  Ma Xiaojun: Actually, in the first topic, we saw that there are many reasons for digestive tract infections, some of which are parasites. In the conventional sense, the treatment of many parasites is also included in antibacterial drugs. The second is bacteria, which must use antibacterial drugs. There is also a virus, a gastrointestinal infection caused by a virus, which is diarrhea. Here we see that only parasites and bacteria are suitable for infection. However, in the early stage of diarrhea, it is not recommended that you do a very strong antidiarrheal treatment. If his diarrhea is very serious and dehydrated, he needs a lot of rehydration, not just simple antidiarrheal, because simple antidiarrheal first hinders the excretion of toxins, and second brings serious obstruction and paralysis, etc., so if it is diarrhea with some symptoms that you can’t stand, Beijing requires all medical institutions to have intestinal clinics at the first time, so you should go to the hospital.

  Li Yuzhen: Elonson is not an anti-inflammatory drug for ordinary people, but a hormone called acid-fast allergy pine, which can treat some skin lesions such as allergic dermatitis or eczema. It is not caused by bacteria, and it is easy to cause skin discoloration or skin atrophy if used for a long time, so it is necessary to see whether your skin is allergic or other reasons. If it is an abscess caused by bacteria, some local drugs should be used. Of course, we sometimes have to use drugs all over the body in clinic, and antibiotics for external use should be used as little as possible, but local small redness and swelling can still be used, which is completely different from hormones, which are used only for allergic dermatitis and eczema.

  V. Conclusion

  Moderator: Finally, we used a little time to ask three guests to sum up from their own perspectives. How can we use antibacterial drugs reasonably? Director Yue talks about how to use antibiotics rationally from the perspective of government supervision. Professor Ma, how do you advise our patients to see a doctor? Professor Li talks about how to guide the public to correctly understand the rational use of antibacterial drugs, including from the perspective of pharmacology.

  Yue Xiaolin: I still want to quote a theme used by two experts in this year’s World Health Assembly: No action today, no medicine available tomorrow. The government must improve the system of laws and regulations, strengthen the management, internal management and external supervision of medical institutions, and strengthen the training of doctors, so as to urge medical and health institutions to use drugs rationally and give everyone a very good and healthy environment.

  Li Yuzhen: As a pharmacist, I would like to tell the netizens that any drug is a double-edged sword, including our antibacterial drugs. We use them well, which benefits us and mankind. If we don’t use them well, it will cause drug resistance and even bring us some consequences that endanger our own lives. Therefore, we should use antibacterial drugs reasonably, which is very important.

  Ma Xiaojun: Our ancient philosophy in China is very good. There is nothing absolutely good or absolutely bad. I suggest that you don’t fear and hate bacteria, because we can’t live without them. We also realize that although everyone is saying that antibacterial drugs are drug-resistant, they have treated a large number of patients who were doomed to die in the past. Therefore, in the field of anti-infection, in addition to the requirements of government management, there is also a very strong academic connotation, which requires doctors to come out. You mentioned teaching netizens to see a doctor. I can’t teach this, but I want to say that what we need most is the trust between doctors and patients. This trust is very important. You have to believe that the doctor will look after you, and his subjective will will definitely look after you. Every doctor wants to treat his patients well, because the patient’s word of mouth is the biggest reward for him, not to mention a good deed for us. Therefore, if netizens want to see a doctor, they should trust the doctor. This is my most important suggestion.

  Moderator: Today, I am very grateful to the three guests for being our guest to talk about medical ethics. I also thank the netizens for their participation. I hope today’s program can give you some advice and help in future medication. This program is here. Goodbye.


Notice of the General Office of Beijing Municipal People’s Government on Printing and Distributing the Implementation Plan of Beijing Vocational Skills Improvement Action (2019-2021)

Beijing Zhengban Fa [2019] No.18

District People’s governments, municipal government commissions, offices and bureaus, and municipal institutions:

  "Beijing Vocational Skills Improvement Action Implementation Plan (2019-2021)" has been approved by the municipal government and is hereby issued to you. Please earnestly organize the implementation.

General Office of Beijing Municipal People’s Government

September 27, 2019

Implementation Plan of Beijing Vocational Skills Promotion Action

(2019-2021)

  In order to thoroughly implement the spirit of the Notice of the General Office of the State Council on Printing and Distributing the Action Plan for Vocational Skills Improvement (2019-2021) (Guo Ban Fa [2019] No.24), this plan is formulated in combination with the actual situation of this Municipality.

  I. General requirements

  Guided by the Supreme Leader’s Socialism with Chinese characteristics Thought in the New Era, we will thoroughly implement the spirit of the 19th National Congress of the Communist Party of China and the Second and Third Plenary Sessions of the 19th Central Committee, regard vocational skills training as a key measure to maintain employment stability and alleviate structural employment contradictions, base ourselves on the actual economic and social development of the capital, adhere to demand-oriented and result-oriented, vigorously implement the lifelong vocational skills training system, and continue to carry out it in accordance with the working ideas of making training information public, cataloguing training items, real-time training evaluation, integrating training resources and making effective use of funds. Strive to reach the end of 2021, the proportion of skilled workers in the total number of employed people in this city will reach 30%, and the proportion of highly skilled talents in skilled workers will reach 33%.

  Two, vigorously carry out vocational skills training for enterprise employees.

  (1) Strengthen the pre-job training of enterprise employees. We will implement the pre-job training system of recruiting new employees, retraining and taking up their posts, and carry out skills training to meet the needs of posts and development. First, for the new employees of the enterprise, if the training time is not less than 40 hours within 12 months after the employee’s employment, the enterprise will be subsidized according to the standard of 500 yuan per person. The second is to implement the new apprenticeship training plan of "recruitment means enrollment, enrollment means enrollment, and joint training of enterprises and schools", and deepen the training mechanism of "jointly building majors, talents and bases". For the new apprentices who implement the training plan for one to three years, according to the urgent need of the industry, the type of occupation, the training level and the implementation effect, the enterprise subsidy will be given according to the standard of 5,000 yuan to 8,000 yuan per person per year. The third is to implement the action plan to improve the safety skills of employees in high-risk industries. After January 1, 2019, employees of enterprises who have newly obtained special operation certificates and special equipment operator certificates and paid unemployment insurance in this city for more than one year will be given personal subsidies according to the standard of 1000 yuan per person.

  (two) to strengthen the post skills training of enterprise employees. Encourage enterprises to carry out on-the-job training, off-the-job training, online learning and other vocational skills training, support enterprises to hold various vocational skills competitions, and improve the quality and service level of employees. Implement three training programs to improve job skills and quality: First, implement job training and upgrading programs. For employees of enterprises who have newly obtained national vocational qualification certificates or vocational skill level certificates such as junior workers, intermediate workers, senior workers, technicians and senior technicians after January 1, 2019, and have paid unemployment insurance in this city for more than one year, they will be given personal skills upgrading subsidies according to the standards of 1000 yuan, 1,500 yuan, 2,000 yuan, 2,500 yuan and 3,000 yuan respectively. Among them, if the identified difficult enterprises carry out national vocational qualification training or vocational skill level training, they will be subsidized according to 50% of the above standards; Difficult enterprises to carry out non-level skills training for enterprise employees and the training time is not less than 20 class hours, according to the standard of 500 yuan per person to give enterprise subsidies. The second is to implement the training plan for high-skilled personnel, support enterprises to organize high-skilled personnel to participate in technical innovation, technological transformation and other training programs, and give each enterprise listed in the training program a training subsidy of not more than 300,000 yuan per year according to the standard of 5,000 yuan per person. The third is to implement the innovative training plan for master skill studios, support enterprises to establish master skill studios, undertake skills inheritance training, technical skills innovation, skills promotion and exchange and other projects, and give each declared and approved project no more than 300,000 yuan in funding every year.

  Three, strengthen the key industries, key areas of vocational skills training.

  (three) the implementation of key industries personnel training plan. Around the top ten high-tech industries in the capital, as well as key industries such as financial technology and cultural and creative industries, skills upgrading training will be included in the industrial service package, and training programs will be developed with demand as the guide. For high-tech industrial enterprises and financial technology enterprises that organize employees to carry out skills upgrading training and pass the examination, they will be subsidized according to the standard of not more than 20,000 yuan per person; For those who have participated in the training and have been employed in relevant enterprises in this city for more than 3 months after the training, they will be given personal incentive subsidies according to 50% of the above standards. Develop training catalogues for creative design, animation production, high-end homestays, old-fashioned skills inheritance and other cultural and creative industries. For those related enterprises that organize employees to carry out skills upgrading training, enterprises will be subsidized according to the standard of not exceeding 5,000 yuan per person.

  (four) the implementation of life service and urban operation security and other key areas of employee training program. In the fields of old-age care, security, medical care, child care, express delivery, etc., if employees are organized to improve their skills and obtain corresponding certificates, they will be subsidized by enterprises or training institutions according to the actual work and the standard that each person does not exceed 3,000 yuan. For enterprises in urban water supply, drainage, heating, gas, landscaping, public transportation, environmental sanitation and other key areas, if they organize employees to carry out skills upgrading training, they will be subsidized according to the standard of no more than 4,000 yuan per person.

  In addition, Beijing Economic and Technological Development Zone, as a pilot area of skills training in this city, can not only enjoy the municipal inclusive policy, but also formulate corresponding training and reward policies according to the regional reality, and the municipal funds will provide supporting support according to the capital investment of the development zone.

  Fourth, strengthen the employment and entrepreneurship training for key groups

  (five) the implementation of free training programs for employment and entrepreneurship of key groups. For the unemployed, rural migrant workers (including low-income farmers), urban and rural junior high school graduates who have not continued their studies, transferred workers, college graduates in this city, retired soldiers, and disabled people, we will continue to implement free training such as labor preparation training, employment skills training, and vocational skills upgrading training. We will continue to carry out rural labor transfer and employment training around key tasks or major projects such as the preparation for the Winter Olympics and Paralympics and the construction of Beijing’s sub-center. Strengthen the public service of entrepreneurship training, innovate entrepreneurship training mode, strengthen the development of entrepreneurship training projects, focus on college graduates in this city, and carry out free entrepreneurship training for key groups that meet the conditions and have entrepreneurial aspirations.

  (six) the implementation of employment difficulties personnel training subsidy program. We will increase assistance to people with employment difficulties. Those who absorb people with employment difficulties and carry out job-based training will be given vocational training subsidies for no more than 6 months according to the 500 yuan standard per person per month. Cost of living allowance during the training period for people with employment difficulties and rural labor force.

  (seven) the implementation of domestic service upgrading and expansion of special training plan. To carry out pre-job training for domestic service personnel, and if the training time per person is not less than 80 class hours per year, the enterprise subsidy will be given according to the standard of 2,000 yuan per person; To carry out "tempering" training, and each person’s annual training time is not less than 40 class hours, the enterprise subsidy will be given according to the standard of 500 yuan per person, among which, the enterprise subsidy will be given according to the standard of 1000 yuan per person for the employee-made domestic enterprises that carry out "tempering" training.

  (eight) the implementation of farmers’ professional quality improvement plan. For new formats such as sightseeing and leisure, rural tourism, under-forest economy, and rural e-commerce, we will establish training catalogues focusing on improving farmers’ professional quality, production skills and management ability, organize and implement free training for farmers mainly by means of government purchasing services, and accelerate the construction of a team of high-quality farmers with culture, technology, good management and management.

  Fifth, mobilize the enthusiasm of the training subjects

  (nine) support enterprises to expand the scale of training. Support all kinds of enterprises, especially enterprises above designated size or enterprises with more employment, to set up employee training centers, carry out vocational skills training for the society, and undertake subsidized training projects. Strengthen the integration of production and education, school-enterprise cooperation, and actively cultivate a number of enterprises with integration of production and education. Support the training base of skilled personnel to organize and carry out skills upgrading training for employees, and give subsidies to the training base according to the standard of no more than 4,000 yuan per person.

  (ten) support vocational colleges to expand the supply of training. Improve the modern vocational education system that pays equal attention to academic education and training, and carry out vocational training for students and all members of society in accordance with the ideas of combining education with training, combining length with length, and combining inside and outside. Accelerate the transformation and development of some municipal universities to applied technology, and carry out vocational skills education and training. To formulate the management measures for vocational training in vocational colleges, and when the total performance pay of vocational colleges is approved, it can be tilted to the units that undertake vocational skills training. Vocational colleges are allowed to incorporate a certain percentage of training income into school public funds, and the school training workload can be converted into full-time student training workload according to a certain proportion. In the internal distribution of vocational colleges, teachers who undertake vocational skills training should be inclined to ensure their reasonable treatment.

  (eleven) support social institutions to participate in vocational skills training and evaluation. Support social forces to organize private vocational skills training institutions, strengthen the management and service of training institutions, improve the evaluation and reward and punishment system, and promote standardized and branded development. In accordance with the requirements of the state, establish and implement a vocational skill level identification system, and support employers and social training evaluation organizations to carry out vocational skill level identification in accordance with relevant regulations. Establish a quality monitoring system for evaluation work, carry out regular evaluation and inspection, and improve the level of evaluation work.

  (twelve) innovative vocational skills training content and mode. Scientifically design the training content, and run the comprehensive training content such as professional ethics, quality awareness, legal awareness, safety production, health and guidance on employment and entrepreneurship throughout the training process. Incorporate new technologies, new processes and new norms into teaching standards and teaching contents, and strengthen practical training. Vigorously develop modern training methods such as "internet plus", encourage the construction of intelligent training platforms, improve teaching methods by using modern information technology, and promote the construction and universal application of online learning spaces such as virtual factories. Promote flexible academic system and credit system, accelerate the construction of "credit bank", and realize traceability, inquiry and conversion of learning results. Set up high-level teachers’ teaching innovation team, carry out cutting-edge technology and knowledge update training, and increase the development and update of distance training courseware.

  (thirteen) to strengthen the basic capacity building of vocational skills training. Actively promote the inventory management of vocational skills training, and publish the catalogue of training and evaluation institutions, so that workers can choose according to their needs. Strengthen the training of vocational training teachers and the construction of expert teams, and promote the co-construction and sharing of vocational skills training resources. Vocational colleges and training institutions implement a full-time and part-time teacher system, and can independently recruit enterprise skilled personnel to teach according to regulations. Strengthen the quality evaluation and supervision of vocational training, and speed up the informatization construction of vocational training management. Implement the real-name management of vocational skills training, supervise the whole training process, and ensure the accurate use of subsidy funds. Each district can support the upgrading of training facilities and equipment of enterprises, colleges and training institutions.

  Sixth, strengthen organizational guarantee

  (14) Improve the working mechanism. Under the unified leadership of the municipal employment leading group, the city’s vocational skills promotion action establishes a working mechanism of group overall planning, urban implementation, industry responsibility, institutional participation, special financial accounts and one network verification. City employment work leading group is responsible for the inter-departmental and cross-level coordination of skills upgrading actions, formulate annual work plans, decompose work tasks, establish and improve special fund payment ledgers, establish work reporting system and supervision and inspection system, and do a good job in task implementation. Departments in charge of various industries and districts should take vocational skills upgrading as an important livelihood project, and strictly implement the skills upgrading training tasks for enterprise employees and key groups in light of the actual situation. Departments in charge of various industries should take the lead in organizing the training of vocational skills improvement in their own systems and fields, formulate relevant support policies, and organize training and fund review. Trade unions, the Communist Youth League, women’s federations and other mass organizations, trade associations, and social training and evaluation institutions should jointly participate in vocational skills training. The financial department should strengthen the supervision of vocational skills training funds, so as to be earmarked and accounted for separately, and ensure that the funds are allocated in full and on time. The human resources and social security department should rely on the information platform for vocational skills upgrading, strengthen communication and coordination with the competent departments of various industries and districts, timely collect data on trainers and subsidies, and realize online comparison, online collection and online statistics.

  (fifteen) increase financial support. The funds used for vocational skills training from special employment funds, talent funds and industry development funds will be used as a whole for vocational skills upgrading actions, and a "special account for vocational skills upgrading actions" will be established separately in the financial special account of social security funds. The relevant policies will be implemented as of January 1, 2019. Workers who meet the relevant training subsidy policies can enjoy no more than three times a year, and the same occupation and the same level cannot be enjoyed repeatedly. Enterprises should fully extract and use employee education funds according to relevant regulations, of which more than 60% are used for front-line employee training, which can be used for enterprise "mentoring" subsidies. Implement the tax policy of increasing the pre-tax deduction limit of enterprise employees’ education funds to 8% of total wages and salaries. Promote enterprises to extract employee education funds to carry out independent training and enjoy policies to carry out subsidized training. Support basic work such as the development of vocational skills training textbooks, teacher training, teaching reform and vocational skills competition, and reward and supplement the training organization and mobilization work.

  (sixteen) to strengthen quality supervision and inspection. Improve the performance evaluation system of vocational skills training and support the development of third-party evaluation. Departments in charge of various industries and districts shall, in combination with the division of work, earnestly perform the duties of reviewing application materials, and effectively identify the authenticity of fund distribution objects and their application materials. It is necessary to strengthen the supervision and inspection of training quality, conduct supervision and evaluation by means of daily supervision, special supervision and annual assessment, regularly organize special audits and performance appraisal, strengthen the prevention and control of integrity risks, and ensure the safety and efficiency of funds. Acts of obtaining or defrauding funds by means of false training shall be dealt with severely according to discipline, law and regulations.

  (seventeen) do a good job in policy interpretation and publicity. Departments in charge of various industries and districts should increase the publicity of vocational skills upgrading actions, promote the disclosure of training information, guide enterprises, training institutions and workers to actively participate in vocational skills upgrading actions, make full use of policies, improve the public awareness of policies, and jointly promote the development of vocational skills training.

  Attachment: 2019 Task Breakdown Table of Beijing Vocational Skills Upgrading Subsidized Training

37- Attachment: 2019 Task Breakdown Table of Beijing Vocational Skills Upgrading Subsidized Training. jpg

How to carve fine products in domestic animation (first-line investigation)

  Li Bai was drunk, splashing wine into water, and cranes appeared in the water.

  Soaring on a giant crane with Gao Shi, Du Fu, Cenfuzi and Dan Qiusheng, "I’m going to drink, and the cup will not stop", which is extremely wild and romantic … … The animated film Three Wan Li in Chang ‘an, which is being shown, has aroused the audience’s resonance with the poetry of Chinese cultural genes. Up to now, the box office of the film has exceeded 1.7 billion yuan.

  China’s animation shows a gratifying trend. In recent years, excellent animated films such as The Return of the Great Sage on the Journey to the West, The White Snake: The Origin, and Ne Zha’s Deep Sea have appeared one after another. Their creative vitality is surging and their box office reputation is good, which sends a clear signal that the animation market in China is booming and has great potential.

  Rooted in the fertile soil of Chinese excellent traditional culture, domestic animation is taking a creative transformation and innovative development road with extraordinary imagination and steady steps, which shows China characteristics, China style and China style.

  Chinoiserie

  Exploring the road of national style and expressing Chinese cultural genes

  [Lens] From the prosperous and inclusive Chang ‘an, to the south of the Yangtze River with flowing bridges, and then to the lonely desert of Saibei, it is concentrated in 48 Tang poems in 168 minutes. The audience in the cinema couldn’t help reading aloud, and comments such as "China culture is the greatest strength of the film" and "Poetry gene surging in the blood" were highly praised … … This is a vivid epitome of the surge of traditional culture in recent years.

  Since the first advertising animation Shu Zhendong’s Chinese Typewriter was released in 1922, China animation has gone through a hundred years. In the ups and downs, the course remains the same, that is, along the background of Chinese excellent traditional culture, "exploring the road of national style."

  Make a scene in heaven, tadpoles looking for their mothers … … Su Da, director of Shanghai Animation Film Studio, recalled, "Among the brilliant group images of China Animation School’s works, there is traditional culture — — Literature, drama, architecture and music have artistic forms with rich national style — — Ink painting, Dunhuang frescoes and New Year pictures have the spiritual connotation of the Chinese nation — — Kindness, tenacity, diligence, courage, etc. "

  Throughout the animated films that have been released in recent years, "national style" and "national tide" are still the key words. Ne Zha endowed the traditional characters with new connotations and created an image of Nezha, who is "my life depends on me". Three Wan Li in Chang ‘an cultivated the feelings of home and country with poetry, and conveyed the cultural core of the Chinese nation such as self-improvement and tolerance. "Big Fish Begonia" beautifully shows the world cultural heritage of Fujian Tulou … …

  "Traditional culture is a magnificent treasure house of China’s animation film creation. The core of China Animation School is nationalization, which is used to show our own literary and artistic image and create a set of expressions based on traditional culture to express Chinese cultural genes." Ma Hua, a professor at the Animation Institute of Beijing Film Academy, concluded this.

  Creating animations with traditional cultural themes is both a leverage and a challenge. Well-known historical figures and stories lower the threshold for the audience to enter the cinema, but test the basic skills of the creators.

  For this reason, the creative team of "Three Wan Li in Chang ‘an" has traveled a lot to collect ideas. "We walked into Shaanxi History Museum to study the layout of Chang ‘an, stood on the ancient wall of Tongguan and felt the tragic mood of Ge Shuhan, and wandered through Songpan ancient city to find the inspiration for designing Yunshan City and Lushuiguan & HELIP; …” Xie Junwei, director of "Three Wan Li in Chang ‘an", introduced that every shot went to the screen wall outside the county magistrate’s house, the wine-raising game played by the literati, and the poem board in the posthouse temple, referring to nearly 100 documents and many unearthed cultural relics. Annotation on the Chronology of Li Bai’s Complete Works and Annotation on Gao Shijia’s Collection are "reference books kept by the team at hand".

  Some directors described animation as "dreaming in a wild way". Free and unrestrained artistic expression is combined with traditional cultural stories, and The Return of the Great Sage of Journey to the West, released in 2015, has become a phenomenal work of domestic animated films. The great potential of mythical themes has been discovered.

  In recent years, the diversification trend of domestic animation themes is remarkable, and realistic animated films have great market potential. For example, the recently released Tea No.2 Middle School is an animated comedy with a campus theme, while the previously released Deep Sea focuses on the exploration of the inner world.

  "The way generations accept knowledge is changing. After 95 s and 00 s, I am used to touching new things through video. I want to attract more people to contact and understand in the form of literature and art that young people like to see, and then love traditional culture more. " Yu Zhou, producer of Chang ‘an Three Wan Li and president of light-chasing animation, said, "Young people’s recognition of China culture makes us believe that the rise of domestic animated films is not only a slogan, but also the present and the future."

  It is also what MCA hopes to broaden the animation creation space and give more animators the opportunity to create diverse works. "There are many dimensions to evaluate an animation work, which can be artistic level or commercial success, but more importantly, it meets the audience’s call and expectation." He hopes that the development of animated films will have more "spirit of doing experiments", keep an open theme, let young practitioners innovate more boldly and consciously, explore the boundaries in different directions, and let more good works be seen by everyone.

  Sense of science and technology

  With the improvement of personnel training, the bottleneck of animation film production capacity is constantly being broken.

  [Lens] "10 years, 7.5 billion frames" — — On the day when Chang ‘an Three Wan Li was finalized, Wei Wang, the founder of light-chasing animation, sent such a Weibo. It is not surprising in the world of animation that the number of "100 million" is often on the order of magnitude. Take Penglai Wonderland, the splendid opening of "The New God List: Yang Jian", as an example. In just a few seconds, the number of single-lens models is 14 billion, the file size is 5TB (terabytes), and the total rendering time of the whole film is 410 million nuclear hours (CPU consumption, measured by nuclear multiplication hours), which requires thousands of servers to work continuously for 24 hours.

  The multiplication of a string of numbers seems a bit "sci-fi", which is behind the inevitable logic of the development of science and technology hard core in the film industry.

  "history of animation, to some extent, is the history of people’s exploration of light and shadow, and the history of the integration of technology and art." Ma Li, president of the Chinese Animation Society, said. As a blend of virtual and reality, with the new generation of network transmission, artificial intelligence, virtual reality, augmented reality, motion capture and other key technologies infiltrating into all levels and links of animation creation, production, communication and consumption, fully integrating with the imagination of creators and empowering each other, animated films bring viewers a higher level of audio-visual enjoyment.

  Compared with the production cycle of a live-action movie for one or two years, an animated movie takes three to five years or even longer, and the project is more complicated. In Ne Zha, for example, special effects shots account for nearly 80%, and more than 60 teams and more than 1,600 producers all over the world have worked intensively for five years, which finally lifted the box office miracle of over 5 billion yuan.

  In fact, complicated production is also a challenge for the whole process coordination, and this challenge needs to return to industrialization itself. According to insiders, the high degree of dispersion in production stage, uneven outsourcing quality and lack of uniform special effects standards once hampered the industrialization level of animation in China.

  With the gradual maturity of industrialization process and the improvement of personnel training in all aspects, the bottleneck of animation film production capacity is constantly being broken. According to industry reports, in 2017, there were no more than 30 enterprises that could fully produce China animation. Today, there are nearly 1,000 upstream and downstream animation enterprises in China, of which 120 can produce high-quality animation. It is worth mentioning that industry observers pointed out that China’s position in the global animation industry chain has obviously improved, from the OEM position at the bottom of the industry "smile curve" to the two ends of the curve with higher yield, and the content production has gradually appeared the trend of "reverse outsourcing".

  Huge groups are exploring in different ways, and they have gathered great synergy to improve the level of domestic animation.

  Walking in the office building of light-chasing animation, you can see the orderly distribution and synchronous operation of the teams corresponding to each link. Pre-design, storyboard, 3D modeling, materials, binding, animation, role special effects, scene special effects, digital painting, lighting synthesis, post-editing, technology, production … … Assemble into a complete chain of animation creation.

  "Almost 100% of the creation of an animated film can be born from this building." Yu Zhou introduced that among the more than 300 people in the team, producers account for about 90%. "We have established three series: new legends, new gods and new cultures. Since its inception, we have set up a creative process of rolling forward three works. The time consumption of each work is stable in three years, and one work is continuously iterated and cycled, driving an industrial system production line."

  How to balance the pursuit of speed in industrialized production and quality in aesthetic expression? On the one hand, stable quality depends on the accumulation of "internal strength". "For example, the liquid and hair problems that were overcome in the production of Cat and Peach Blossom Garden can be directly applied to Shen Gongbao’s mount in The New God List: Yang Jian, and the technology is like ‘ Snowball ’ Accumulate the same. " Yu Zhou said that on the other hand, it is to optimize the process. "There is a working tradition of chasing light. After each film project is completed, all links will hold a project summary meeting to summarize the achievements and put forward the goals for future promotion and development. Every movie that chases light is based on the experience of the last one. "

  Original and subversive innovation not only depends on the improvement of "tools", but also tests the determination of "people". Director Tian Xiaopeng spent seven years in Deep Sea, brewing an experiment on visual effect innovation: the original "particle ink painting" style, combining blank freehand brushwork ink painting with concrete realistic three-dimensional innovation, blending traditional colors of Chinese painting with western impressionist art, and creating a dreamy deep sea world.

  "In the process of creation, in order to restore the elegance and graininess of ink painting, we mixed detergent, propylene, food coloring, milk, etc., and repeated it over and over again for more than 100 times." Tian Xiaopeng said that all technological innovations are for content service, and the "sea-splitting" lens in the film is dismantled. The single lens has more than 100 layers of particle special effects, and the number of particles is as high as several billion, which creates a subtle and extremely real scene texture.

  How to find the unique 3D animation style of China? In Tian Xiaopeng’s mind, the combination of two-dimensional and three-dimensional and the exploration of their boundaries may be one of the breakthroughs. "Two-dimensional animation is inherently subjective, but in terms of immersion, lens and light and shadow, three-dimensional animation is more mature, and China animation provides a unique possibility by organically combining their respective advantages." This idea germinated when making the title of The Return of the Great Sage on the Journey to the West, and accumulated more mature processes and methods in Deep Sea. "Innovation is the driving force behind my animation." Tian Xiaopeng said.

  influence

  Create more cultural IP carriers and let the story of China go to the international stage.

  [Lens] Back in 1964, Shanghai Meiying Factory assembled the "strongest lineup" to create the first color animated feature film "Make a scene in Heaven". The film has been exported, distributed and screened to 44 countries and regions, and has participated in more than 10 international film festivals and won many awards, ranking first in the world in terms of aesthetic expression and technical level. After a lapse of nearly 60 years, Shanghai Meiying Factory led the creation and jointly produced the animated short film collection "China Qitan" with bilibili. The Chinese national spirit and oriental aesthetic style returned with the attitude of "new generation" to tell the world the story of China.

  How can the splendid Chinese excellent traditional culture IP "go out" and further live and fire? "Don’t imitate others, don’t repeat yourself" is the consistent creative concept of Shanghai Meiying Factory, and it is also the key for domestic animation to go out.

  "In the past, Hollywood, Disney and Pixar were the templates for our creation, but the market response was not satisfactory and the audience did not buy it." Ma Hua said that from imitation to partial originality and then to pure originality, it is the only way for China animation to grow, "‘ Copy ’ You can learn skills and experience, but the direction of the topic, the aesthetic system and the spiritual core conveyed by the story are all misplaced. "

  In this regard, Tian Xiaopeng also has personal pain: "When I was doing The Return of the Great Sage on the Journey to the West, I was often asked a question, what is our own oriental performance?" After many years, the creator slowly found his own context. "The story, art and performance are all oriental, and the national style naturally flows in the blood of domestic animation."

  Under the gaze of the world, exploring the road of national style has become the trend of China School, and the animation works bearing the genes of Chinese excellent traditional culture have once again attracted attention. Behind it, there are unique Chinese visual arts, constantly improving animation production technology, and ambitious faces like young Li Bai and Gao Shi.

  With the "14th Five-Year Plan for China Film Development" clearly pointing out to support animated films that highlight the spirit of the Chinese nation and the oriental aesthetic style, the Chinese Writers Association has helped China to create original animation, and a series of measures have stimulated more and more creative vitality. The recently concluded China Animation Week attracted 71 social organizations and industry companies to participate, displaying more than 500 IP projects and reaching 83 cooperation intention projects on the spot; In the 19th China International Cartoon & Animation Festival held in June, 567 Chinese and foreign enterprises and institutions, 2,305 exhibitors, merchants and professionals from 67 countries and regions participated in the exhibition, and the intended signing amount reached 1.485 billion yuan, which played a positive role in promoting international exchange of animation and promoting domestic excellent animation to go abroad.

  Opening a vast "chapter" of animation, people deeply witness the exploration and progress, trend and ambition of China’s animation.

  Today’s animation is not only a literary style, but also a comprehensive tide play, game e-sports, digital entertainment, immersive experience theme park and peripheral products, which gives creators a broader space. The data shows that the total output value of animation industry in China has exceeded 220 billion yuan, and animation has become one of the mainstream content categories. Animation+tourism, animation+performing arts, animation+design, animation+games, animation+parenting education, etc., further stimulate the industrial potential of animation art.

  "The vitality of Chinese culture not only depends on the work itself to carry forward and inherit, but also comes from the operation of IP." According to Suda, Shanghai Meiying Factory has continuously strengthened the management of copyright and trademarks in recent years, and registered more than 1,500 trademarks around 40 categories such as clothing, food and toys, building a new ecology of IP transformation.

  Looking forward to the future, Ma Li believes that the two-way empowerment of new technologies, new applications and the operation of the whole industry chain will become an important way for China animation to develop by leaps and bounds. "Standing at a new historical starting point, the animation industry in China should strive to anchor the three goals of improving the originality of fine products, industrial competitiveness and international influence, show a new atmosphere in promoting the high-quality development of China animation, and provide a strong boost for enhancing the cultural confidence of the Chinese nation."

  "Do China animation with ideals and quality, China animation with cohesion, and China animation that can be handed down from generation to generation." Ma Li’s appeal is also the voice of many animators. With fine works, we can create a long history and write a chapter of the era. Dapeng holds high and crosses the sky of China, bringing enough wind to stir and continue.

  — — "As long as the poem is there and the book is there, Chang ‘an will be there."

Announcement of Listed Companies in Shanghai Stock Exchange (September 7th)

  Tasly: Bortezomib for injection obtained the drug registration certificate.

  () On the evening of September 6th, it was announced that Jiangsu Diyi, a wholly-owned subsidiary, had obtained the registration certificate of bortezomib for injection. Bortezomib, as one of the anti-tumor drugs, is used to treat multiple myeloma and mantle cell lymphoma.

  Tasly subsidiary obtained the registration certificate of bortezomib for injection.

  Tasly announced that recently, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. ("Jiangsu Diyi"), a wholly-owned subsidiary of the company, received the Pharmaceutical Registration Certificate on bortezomib for Injection approved and issued by National Medical Products Administration.

  It is reported that bortezomib is a bispeptide borate analogue, and it is the world’s first artificially synthesized new competitive inhibitor of proteasome for clinical use. As one of the anti-tumor drugs, bortezomib is used for the treatment of multiple myeloma and mantle cell lymphoma.

  According to the announcement, bortezomib for injection is another anti-tumor injection product that the company obtained the drug registration certificate after the approval of temozolomide for injection, which is regarded as passing the consistency evaluation, further enriching the company’s product pipeline. Jiangsu Diyi also produces bortezomib raw materials, which has advantages in effectively controlling production costs, and at the same time, the quality and supply of this variety of raw materials can be better guaranteed.

  Zhao Huaizhi, the shareholder of Zhonggong Hi-Tech, reduced his holdings by 1.58%, and reduced his holdings by more than half.

  () Announcement: As of September 5, 2022, Zhao Huaizhi, a shareholder of the company, reduced his holdings by a total of 1,052,500 shares through centralized bidding and block trading, accounting for 1.58% of the total shares of the company. More than half of his holdings have been reduced, and his shareholding ratio has dropped to 4.44%.

  Kindick was notified of the approval of the supplementary application for "tetravalent influenza virus split vaccine"

  Kindike announced that recently, the company received the Notice of Approval for Supplementary Drug Application issued by National Medical Products Administration (hereinafter referred to as "National Medical Products Administration"), and the name of the drug was tetravalent influenza virus split vaccine.

  Kindick: Get the approval notice of the supplementary application for tetravalent influenza virus split vaccine.

  Kindick announced on the evening of September 6 that he had obtained the approval notice for the supplementary application of tetravalent influenza virus split vaccine. This approval is conducive to expanding the market share of products.

  Kindick: Notice of Approval for Supplementary Application for Tetravalent Influenza Virus Split Vaccine

  On September 6, the financial sector announced that Kindick had obtained the approval notice for the supplementary application of tetravalent influenza virus split vaccine, including the expansion of the preparation scale.

  An Kai bus and Foday battery set up a joint venture company to build a new energy power battery factory.

  () Announce that, at the time of rapid development of global new energy industry, in order to meet market challenges, Company (Party D) and Anhui () Group Co., Ltd. ("Jianghuai Automobile", Party A), Foday Battery Co., Ltd. ("Foday Battery", Party B) and Zhejiang Storage Energy Group Co., Ltd. ("Zhejiang Storage Energy", Party C), on the basis of equality, voluntariness, mutual benefit and common interests.

  Sifang plans to jointly invest and set up a joint venture company, which will build a new energy power battery factory (power battery factory) and carry out new energy power battery production projects with a production scale of 10GWh-20GWh. The products are mainly used in commercial vehicles and other markets. The production scope of the joint venture company includes but is not limited to phosphate cathode materials, layered transition metal oxide cathode materials and blade batteries based on the mixed systems of the above materials.

  The registered capital of the joint venture company is RMB 1 billion, of which Party A plans to contribute RMB 200 million in cash, accounting for 20% of the registered capital of the joint venture company; Party B intends to invest in cash and other rights and interests at a fixed price, with a total investment of RMB 120 million (including cash investment of not less than RMB 50 million), accounting for 12% of the registered capital of the joint venture company; Party C intends to contribute RMB 230 million in cash, accounting for 23% of the registered capital of the joint venture company; Party D intends to contribute RMB 450 million in cash, accounting for 45% of the registered capital of the joint venture company.

  The company said that the signing of the joint venture framework agreement aims to give full play to the advantages of all parties and achieve win-win cooperation and coordinated development in the field of new energy through complementary advantages and resources. At the same time, it is conducive to further enhancing the company’s competitiveness, laying a solid foundation for the company’s transformation business breakthrough, and has a positive impact on consolidating the company’s new energy business development.

  Baiyun Airport: Passenger throughput in August increased by 52% year-on-year.

  The financial sector announced on September 6th that there were 31,691 flights in August, up by 29.49% year-on-year. In August, the passenger throughput was 3,487,500, a year-on-year increase of 51.73%.

  The controlling shareholders and concerted parties of Suli Co., Ltd. reduced their holdings of convertible bonds by 10% of the total issued amount.

  () Announcement: On September 6, 2022, Miao Jinfeng, the controlling shareholder of the company, reduced 783,200 "Suli Convertible Bonds", accounting for 8.18% of the total issuance, and its concerted action person, Ningbo Meishan Bonded Port Gusheng Investment Co., Ltd. ("Gusheng Investment") reduced 174,000 "Suli Convertible Bonds", accounting for 1.82% of the total issuance. After the completion of this reduction, Miao Jinfeng holds 2,233,600 "Suli Convertible Bonds", accounting for 23.33% of the total issuance; Gusheng Investment holds 601,900 "Suli Convertible Bonds", accounting for 6.29% of the total issuance.

  Li Hao, director and vice president of Gravitation Media, intends to reduce his holdings by no more than 100,800 shares.

  () Announcement, Li Hao, the director and vice president of the company, plans to reduce his holdings by no more than 100,800 shares within six months after 15 trading days from the date of this announcement by means of centralized bidding or block trading and other laws and regulations, accounting for 0.038% of the total shares of the company.

  A total of 68,000,200 shares of the employee stock ownership plan of Industrial Securities have been reduced.

  Industrial Securities announced that during the period from September 3, 2018 to September 5, 2022, 47.669 million shares of the company held by the company’s first employee stock ownership plan were all reduced through centralized bidding transactions. During the period from September 1, 2020 to September 5, 2022, all the 20,331,200 shares of the company held by the company’s second employee stock ownership plan were reduced through centralized bidding. The company and Xingzheng Asset Management will complete the liquidation and income distribution of related assets according to the provisions of the employee stock ownership plan.

  Xingfa Group: Signed a cooperation framework agreement with Xinya Process

  The financial sector announced on September 6th that the company and () signed a cooperation framework agreement to jointly invest in the construction of electronic adhesive products, and the first phase of the construction of 30,000 tons/year electronic adhesive products.

  Tianma technology set up a subsidiary in Hubei to expand its business

  () Announcement: Based on the strategic layout of the whole industrial chain and the needs of business expansion, the company has invested abroad to establish a wholly-owned subsidiary, Hubei tianma technology Industrial Co., Ltd., with a total registered capital of 100 million yuan.

  An Kai Bus: It is planned to jointly build a new energy power battery production factory with Jianghuai Automobile and others.

  An Kai Bus announced on the evening of September 6th that the company had signed a joint venture framework agreement with Jianghuai Automobile, Foday Battery Co., Ltd. and Zhechu Energy Group Co., Ltd. on the cooperation of power batteries. Sifang plans to jointly invest and set up a joint venture company to build a new energy power battery production plant and carry out new energy power battery production projects. The production scale of this project is 10GWh-20GWh, and the products are mainly used in commercial vehicles and other markets. Jianghuai Automobile is the controlling shareholder of the company. The registered capital of the joint venture company is 1 billion yuan, and Jianghuai Automobile plans to contribute 200 million yuan in cash, accounting for 20%; An Kai Bus plans to contribute 450 million yuan in cash, accounting for 45%.

  Xingfa Group and Xinya Process signed a cooperation framework agreement to jointly invest in the construction of electronic adhesive products.

  Xingfa Group announced that on September 6, 2022, the company ("Party A") and () Process (Guangdong) Co., Ltd. ("Xinya Process" and "Party B") signed the Cooperation Framework Agreement in Yichang City, Hubei Province. Party A and Party B unanimously agree that a new legal entity (the "new company") will be established in Xiaoting District, Yichang City at the capital contribution of both parties or their affiliated companies. After the establishment, the new company will devote itself to the research, development, production and sales of electronic adhesive products. The registered capital of the new company is 50 million yuan, of which Party A holds 49% and Party B holds 51%. The new company plans to build electronic adhesive products in stages at one time, covering an area of 100 mu, including 30,000 tons/year of electronic adhesive products in the first phase.

  As shown in the announcement, Xinya Process has been deeply involved in the related industries of electronic processes for many years, forming a high-security and low-cost product supply chain. The core product electronic glue has formed a dominant position in the field of consumer electronics, and is committed to expanding into new energy vehicles, photovoltaic power plants, energy storage battery systems, MiniLED and other fields.

  It is reported that in order to promote the transformation, popularization and application of the new company’s scientific and technological achievements in the field of electronic adhesive technology, Party A and Party B will cooperate in all aspects of technology, and Party A will open scientific research centers including but not limited to Hubei Three Gorges Laboratory to Party B and the new company, and give priority to recommending outstanding scientific and technological achievements in related fields to the new company.

  Xingfa Group: Signed a cooperation framework agreement with Xinya Process to build electronic adhesive products.

  Xingfa Group announced on the evening of September 6 that the company signed the Cooperation Framework Agreement with Xinya Process. It is planned to set up a new legal entity in Xiaoting District, Yichang City, funded by both parties or their affiliated companies. After the establishment, the new company will devote itself to the research and development, production and sales of electronic adhesive products. The registered capital of the new company is 50 million yuan, and the company’s shareholding ratio is 49%. The new company plans to build electronic adhesive products in stages at one time, covering an area of 100 mu, including 30,000 tons/year of electronic adhesive products in the first phase.

  An Kai Bus and Jianghuai Automobile signed a joint venture framework agreement to jointly invest in the establishment of a () power battery production plant.

  On the evening of September 6th, An Kai Bus announced that it had reached a consensus with Anhui Jianghuai Automobile Group Co., Ltd. (hereinafter referred to as "Jianghuai Automobile"), Foday Battery Co., Ltd. (hereinafter referred to as "Foday Battery") and Zhejiang Storage Energy Group Co., Ltd. (hereinafter referred to as "Zhejiang Storage Energy") on the cooperation of power batteries and signed the Joint Venture Framework Agreement on September 6th.

  Specifically, the Quartet plans to jointly invest in the establishment of a joint venture company, which will build a new energy power battery production plant and carry out new energy power battery production projects. The registered capital of the joint venture company is 1 billion yuan, of which Jianghuai Automobile plans to contribute 200 million yuan in cash, accounting for 20% of the registered capital of the joint venture company; Foday Battery plans to invest in cash and other rights and interests, with a total investment of 120 million yuan (including cash investment of not less than 50 million yuan), accounting for 12% of the registered capital of the joint venture company; Zhechu Energy plans to contribute 230 million yuan in cash, accounting for 23% of the registered capital of the joint venture company; An Kai Bus plans to contribute 450 million yuan in cash, accounting for 45% of the registered capital of the joint venture company.

  An Kai Bus said that the signing of the joint venture framework agreement, the establishment of a joint venture company, the construction of a new energy power battery production plant and the development of new energy power battery production projects are aimed at giving full play to the advantages of all parties, and achieving win-win cooperation and coordinated development through complementary advantages and resources. At the same time, it is conducive to further enhancing the company’s competitiveness, laying a solid foundation for realizing the company’s transformation business breakthrough, having a positive impact on consolidating the company’s new energy business development, and meeting the company’s strategic development needs and the interests of all shareholders.

  Zhang Maoyi, the actual controller of Jiansheng Group, reduced his shareholding by 4%.

  () Announcement was issued. As of the disclosure date of this announcement, Mr. Zhang Maoyi, the controlling shareholder and actual controller, has reduced the company’s unrestricted shares by 15.25 million shares, accounting for 4.00% of the company’s total share capital. The implementation of this reduction plan has been completed.

  Zhewen Film: It is planned to sell some properties of Century Changlong, a wholly-owned subsidiary.

  () On the evening of September 6th, it was announced that the company planned to sell the office building of Century Changlong Film and Television Co., Ltd., a wholly-owned subsidiary, located in Building 12, Zone G, Gulou District Software Park, Fuzhou City, Fujian Province through Fujian Property Rights Exchange Center. The listing price was not lower than the estimated price of 33.3317 million yuan.

  Zhewen Film intends to sell some properties of its subsidiary Century Changlong.

  Zhewen Film announced that due to the streamlining of the business of Century Changlong, a wholly-owned subsidiary of the company, there is no need to use large-scale office buildings. In order to revitalize assets and promote cash return, the company plans to sell its office building located in Building 12, Zone G, Gulou Software Park, Fuzhou City, Fujian Province through Fujian Property Rights Exchange Center. The listing price is not lower than the evaluation price of 33,331,700 yuan, and the final transaction amount is subject to the public transaction results.

  *ST Ronghua and relevant responsible persons received a warning letter from Gansu Securities Regulatory Bureau.

  () Announcement: On September 6, 2022, the company received the Decision of Gansu Supervision Bureau of China Securities Regulatory Commission ("Gansu Securities Regulatory Bureau") on the Supervision and Management Measures of Gansu Ronghua Industrial (Group) Co., Ltd.. Liu Yong, Chairman and General Manager of the Company, and Li Qinghua, Director, Deputy General Manager and Chief Financial Officer, received the Decision on Taking Supervision and Management Measures of Issuing Warning Letters to Liu Yong and the Decision on Taking Supervision and Management Measures of Issuing Warning Letters to Li Qinghua from Gansu Securities Regulatory Bureau.

  After investigation, the company failed to accurately estimate the provision for inventory depreciation and the estimated liabilities for illegal guarantee before the disclosure of the performance forecast on January 27, 2022, resulting in a difference of 69.4% between the forecast performance disclosed by the company and the actual performance, and failed to prompt the company that its net assets were negative in time, so the stock will be warned of relevant risks by delisting risk, which violates relevant regulations. As the company’s chairman and general manager, directors, deputy general manager and chief financial officer, Liu Yong and Li Qinghua failed to perform their duties faithfully and diligently, and were the main responsible persons for the above-mentioned violations of the company.

  According to the relevant regulations, Gansu Securities Regulatory Bureau decided to take the supervision and management measures of issuing warning letters to the company, Liu Yong and Li Qinghua, and record them in the integrity files of the securities and futures markets.

  Lushan New Materials granted 1.38 million restricted shares at a price of 33.36 yuan/share.

  () Announcement: The conditions for granting restricted shares for the first time stipulated in "Guangzhou Lushan New Materials Co., Ltd. 2022 Restricted Stock Incentive Plan (Draft)" have been achieved. The company decided to take September 5, 2022 as the first grant date, and granted 1.38 million restricted shares to 51 eligible incentive targets for the first time at the grant price of 33.36 yuan/share.

  Taiji Group: Levofloxacin and Sodium Chloride Injection was approved to increase the specification and supplement the approval.

  () On the evening of September 6th, it was announced that Southwest Pharmaceutical Co., Ltd., a holding subsidiary, received the approval notice from National Medical Products Administration on the application for drug supplement of levofloxacin and sodium chloride injection, and the application was to increase the drug specifications.

  There is a big difference between the performance forecast and the actual performance *ST Ronghua and related personnel received a warning letter from Gansu Securities Regulatory Bureau.

  On the evening of September 6th, *ST Ronghua announced that the company, its chairman and general manager Liu Yong and its director, deputy general manager and chief financial officer Li Qinghua had recently received a warning letter from Gansu Securities Regulatory Bureau.

  It is understood that *ST Ronghua did not accurately estimate the inventory depreciation reserve and the estimated liabilities for illegal guarantee before the performance forecast was disclosed on January 27, 2022, resulting in a difference of 69.4% between the forecast performance and the actual performance disclosed by *ST Ronghua, and did not promptly remind the net assets to be negative, and the stock will be warned of the risks related to delisting risk, which violates the first paragraph of Article 3 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.182 of the CSRC). Liu Yong and Li Qinghua, as the chairman and general manager, directors, deputy general managers and chief financial officers of *ST Ronghua, failed to perform their duties faithfully and diligently, and were the main responsible persons for the above-mentioned violations of *ST Ronghua.

  Gansu Securities Regulatory Bureau said that according to the relevant provisions of the Measures for the Administration of Information Disclosure of Listed Companies, Gansu Securities Regulatory Bureau decided to take the supervision and management measures of issuing warning letters to companies, Liu Yong and Li Qinghua, and record them in the integrity files of the securities and futures markets.

  Tasly lisinopril hydrochlorothiazide tablets "over-rated" for the treatment of hypertension.

  On September 6th, Tasly announced that Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (hereinafter referred to as "Jiangsu Diyi"), a wholly-owned subsidiary of Tasly, received the Notice of Approval for Supplementary Application of Lisinopril Hydrochlorothiazide Tablets issued by National Medical Products Administration, and approved the drug to pass the consistency evaluation of generic drug quality and efficacy.

  Lisinopril hydrochlorothiazide tablets are used to treat hypertension, and they are Class B varieties in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2021). The drug was accepted by CDE on August 2, 2021, and recently obtained the Notice of Approval for Supplementary Drug Application issued by National Medical Products Administration. Up to now, Jiangsu Diyi has invested 11,832,200 yuan in R&D for consistency evaluation of this drug. At present, there are two enterprises in the domestic market with the approval number of lisinopril hydrochlorothiazide tablets, and Tasly is the first enterprise to pass the consistency evaluation of this drug. According to the data of the chemical medicine medical terminal in Minenet, the annual sales of lisinopril hydrochlorothiazide tablets in domestic urban public, urban community, county-level public and township health departments in 2021 was 45.52 million yuan.

  Hua ding shares: The General Administration of Market Supervision does not conduct further review on the case of True Love Group’s acquisition of company equity.

  () Announcement: A few days ago, True Love Group Co., Ltd. ("True Love Group") has received the Decision of No Further Review for Centralized Anti-monopoly Review of Operators issued by the State Administration of Markets. The details are as follows:

  "According to the provisions of Article 25 of the Anti-monopoly Law of the People’s Republic of China, after preliminary examination, it is decided that the case of True Love Group Co., Ltd. acquiring the equity of Yiwu Huading Nylon Co., Ltd. will not be further examined. Your company can implement centralization from now on. The case involves matters other than the centralized anti-monopoly review of operators and is handled in accordance with relevant laws. "

  Wan Liyang: The holding subsidiary signed a strategic cooperation framework agreement with wan huitong Energy Company.

  () On the evening of September 6th, it was announced that Zhejiang Wan Liyang Energy Technology Co., Ltd. (hereinafter referred to as "Wan Liyang Energy Company") and Wan () Technology Co., Ltd. (hereinafter referred to as "wan huitong Energy Company"), the holding subsidiaries of the company, signed a strategic cooperation framework agreement, and the two parties will carry out all-round strategic cooperation in power market operation management, green electricity operation management and carbon assets operation management of new energy power plants and pumped storage power plants for a period of five years.

  Bohui Paper invested 860 million yuan to buy back shares, accounting for 6.04%.

  () Announcement was issued. As of September 6, 2022, the company has bought back 80.77 million shares by centralized bidding, accounting for 6.04% of the company’s total share capital. The highest transaction price is 19.62 yuan/share, and the lowest transaction price is 6.70 yuan/share. The total amount paid is 860 million yuan (excluding transaction fees such as commission). This share repurchase is in compliance with laws and regulations and the company’s share repurchase plan.

  Du Yulin, the controlling shareholder of Zhongwang Software, has accumulated 73,800 shares of the company.

  Zhongwang Software announced that as of September 6, 2022, Mr. Du Yulin, the controlling shareholder, actual controller, chairman and general manager of the company, increased his holdings of 73,800 shares through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 0.085% of the total share capital of the company, and the total amount paid was RMB 10,690,500 (excluding transaction costs), which exceeded 50% of the lower limit of the planned increase. The implementation of this shareholding plan has not been completed, and Mr. Du Yulin will continue to increase the company’s shares in accordance with the relevant shareholding plan within the implementation time of the shareholding plan.

  Wan Liyang subsidiary and wan huitong Energy Company reached a strategic cooperation on the operation of new energy-related power stations.

  Wan Liyang announced that on September 6, 2022, Zhejiang Wan Liyang Energy Technology Co., Ltd. (referred to as "Wan Liyang Energy Company") and wan huitong Energy Technology Co., Ltd. (referred to as "wan huitong Energy Company"), a holding subsidiary of the company, signed the Strategic Cooperation Framework Agreement.

  The two sides will carry out all-round strategic cooperation in power market operation management, green electricity operation management and carbon assets operation management of new energy power stations and pumped storage power stations, and the value-added benefits generated by the relevant projects of wan huitong Energy Company through the professional operation management services of Wan Liyang Energy Company will be enjoyed by both parties at 50% each.

  According to the company, the signing of the strategic cooperation agreement will give full play to Wan Liyang Energy Company’s technical strength and rich experience in power market operation and management, green certificate and green electricity operation and management, and carbon asset operation and management, and provide professional services for the power stations under wan huitong Energy Company, which will help to further improve the operating efficiency of wan huitong Energy Company, and effectively enhance the profitability of Wan Liyang Energy Company through revenue sharing. At the same time, combined with the advantages of wan huitong Energy Company’s project resources, Wan Liyang Energy Company can further increase its market share in related business fields and continuously expand its business scale.

  Qinghai Huading real controller acted in concert to create Dongfang Fidelity Investment to reduce its shareholding by 0.73%.

  () Announcement was issued. On September 6, 2022, the company received the Notice on the Progress of the Share Reduction Plan from Shenzhen Chuangdongfang Fidelity Investment Enterprise (Limited Partnership) ("Chuangdongfang Fidelity"), which was the concerted action of the actual controller of the company. From September 2, 2022 to September 6, 2022, Chuangdongfang Fidelity reduced its shares by centralized bidding, accounting for 0.73% of the company’s total share capital.

  The actual controller of Yongjin Co., Ltd. and its concerted parties reduced their holdings of "Yongjin Convertible Bonds" by 1,106,600.

  () Announcement, the company received a notice from the controlling shareholder and actual controller, Mr. Yuji Qu (YUJIQUN), informing Mr. Yuji Qu (YUJIQUN), Ms. Cao Peifeng and their concerted actions, Ms. Cao Jingfen, Mr. Cao Wancheng and Mr. YUJASONCHEN (Yu Chenjie) to reduce their holdings of "Yongjin Convertible Bonds" by centralized trading in the Shanghai Stock Exchange system recently, accounting for 1,106,600.

  Shanghai Pharmaceutical plans to set up a biomedical frontier industry innovation center with Zhangjiang Group and other 920 million yuan.

  () Announcement: As one of the shareholder units, the company plans to jointly establish Shanghai Biomedical Frontier Industry Innovation Center Co., Ltd. ("Frontier Innovation Center") with Shanghai Overseas Co., Ltd. ("Shanghai Overseas"), Shanghai Second Medical Investment Management Co., Ltd. ("Second Medical Investment") and Shanghai Zhangjiang (Group ") with a registered capital of 9.20.

  The announcement shows that Zhangjiang Group, as the main force in the construction of Zhangjiang Science City, the promoter of emerging industries, and the creator of science and technology, undertakes important functions such as development and construction, project introduction, industrial cultivation, functional services, and the creation of an innovative and entrepreneurial atmosphere. Second Medical Investment is a wholly-owned subsidiary of Shanghai Jiaotong University School of Medicine, which is responsible for foreign business and investment. Shanghai Jiao Tong University School of Medicine is a first-class medical school in China.

  It is reported that the Frontier Innovation Center is positioned to carry out innovative research and development from new target discovery to phase II clinical research, gather the cutting-edge scientific research forces of "famous schools", "famous enterprises" and "famous hospitals" in Shanghai, adopt market-oriented operation mode, introduce high-end talents through various forms, closely follow the research and development process of new drugs from the discovery of lead compounds to the acquisition of candidate drug molecules, and then to clinical research (before phase II clinical research), and build a systematic, efficient, high-level and self-built system.

  Jianghe Group’s subsidiary won the bid of 452 million yuan for the curtain wall subcontracting project of Huawei’s Shanghai Qingpu R&D and production project.

  () Announcement: Beijing Jianghe Curtain Wall System Engineering Co., Ltd., a wholly-owned subsidiary of the company, recently received a bid-winning notice from Huawei Technologies Co., Ltd. for the curtain wall subcontracting project (bid 5) and (bid 6) of Huawei’s Shanghai Qingpu R&D and production project, with a total bid-winning amount of RMB 452 million, accounting for 2.17% of the company’s annual operating income in 2021.

  The project is located in Qingpu District, Shanghai, with a total curtain wall area of about 243,700 square meters and an estimated total construction period of 381 days. After the project is completed, it will become an important research and development place for Huawei Technologies Co., Ltd..

  Jiangxi-Guangdong Expressway: China Association of Interbank Market Dealers accepted the company’s registration and issued 4 billion yuan of ultra-short-term financing bonds.

  () Announced that the company received the Notice of Acceptance of Registration from China Association of Interbank Market Dealers (Zhongshi Xiezhu [2022] SCP 324), and the association accepted the registration of the company’s ultra-short-term financing bonds, with the registered amount of the company’s ultra-short-term financing bonds being 4 billion yuan.

  Jiaao Environmental Protection plans to invest in the first phase of the 1 million tons/year bio-jet fuel project, with an investment of about 4 billion yuan.

  () Announced that the company signed the Project Cooperation Agreement with the Guanyun County People’s Government, and the company plans to invest in new biomass energy and new biomass materials projects in the Lingang Industrial Zone of Guanyun County.

  The project plans to invest in new biomass energy and new biomass materials. The 1 million tons/year bio-jet coal project of new biomass energy project will be built in two phases, of which the first phase plans to invest about 4 billion yuan to build a 500,000 tons/year bio-jet coal project, which is scheduled to start construction in January 2023.

  According to the announcement, the establishment of the company is based on the needs of the company’s future development strategy, which is conducive to the company’s reinforcement of the existing biodiesel industry chain, and can effectively promote the company to make full use of its own advantages to upgrade its products and expand the company’s profit space.

  Xin ‘an shares: A performance briefing was held on September 5th.

  On September 6, 2022 (), it was announced that the company held a performance briefing on September 5, 2022.

  The details are as follows:

  Q: Based on the product price announcement in the second quarter, the profit in the second quarter has not decreased much compared with the price drop. What caused the price to decrease and the profit didn’t decrease much?

  A: Compared with the first quarter, the company’s product prices in the second quarter have declined, but at the same time, the prices of some raw materials (such as glycine) have dropped significantly compared with the first quarter, and the sales of some products (such as glyphosate raw materials and preparations) have also increased significantly compared with the first quarter. In addition, the optimization of product structure will also have a greater impact on the benefits. Therefore, there are many factors that affect profits, and the price of products is only one of them.

  Q: How was the company’s operation in the third quarter? How is the inventory?

  A: Please pay close attention to the company’s relevant announcements about the operating performance in the third quarter! As the third quarter has not yet ended, it is still too early to predict, but from the current market changes, the performance of the prices of major products in the industry, and the annual overhaul of the company’s equipment in September, it is expected that the second quarter may be in a weak trend. At present, the company’s inventory is in a normal state.

  Q: The semi-annual report shows that the production and sales of two products in the company do not match, and the production is seriously greater than the sales. Is the product surplus or the product unsalable?

  A: The output of the company’s original drugs, cyclic siloxanes, siloxane intermediates and metallic silicon products is seriously greater than the sales volume, which is mainly caused by the self-use of the upstream and downstream of the internal industrial chain, and there is no product surplus and unsalable sales.

  Q: What is the current situation of the company’s glyphosate orders? What is the company’s judgment on the glyphosate boom in the next two years?

  A: At present, the company has fully produced and sold glyphosate, and it has been scheduled for production in October. From the supply side, the new capacity of glyphosate industry will still be limited under the trend of supply-side reform and environmental protection normalization. With the gradual liberalization of domestic genetic modification, the relationship between supply and demand of glyphosate will be in a tight balance in the visible period. The demand side is affected by the outbreak of epidemic and geopolitics, and countries around the world put food security in a very important strategic position. With the rapid rise of global agricultural products prices, the global cultivated land area continues to increase, and farmers’ enthusiasm for planting has increased, which has brought support to the high prices of agricultural materials such as fertilizers and pesticides.

  Q: What is the company’s silicone cost and gross profit per ton at present?

  A: At present, the cost in silicone has indeed changed, especially with the price fluctuation of industrial silicon and methyl chloride, which has brought about some impacts, including ups and downs. The overall cost has not changed much. The basic products in silicone have been greatly affected by market price changes, but the profitability of end products and special monomers in silicone has remained relatively stable. Overall gross profit per ton benefits from a complete silicon-based industrial chain and relatively maintains the leading level in the industry.

  Q: What is the production and operation status of the company now? Key silicone, is glyphosate fully produced and sold? The impact of changes in domestic and international environment on the company.

  A: At present, the company’s production and operation are normal, and silicone and glyphosate are in a state of full production and sales except for normal annual maintenance. The company pays close attention to the domestic and international environment and market changes, and adjusts its business strategy in time according to market conditions to ensure the maximum benefit of the company.

  Q: At present, the raw materials of glyphosate in the company, yellow phosphorus and glycine, have fallen sharply. What is the profit of glyphosate in the company now? What is the approximate cost per ton? How much will the depreciation of RMB against the US dollar bring to the company? Thank you.

  A: The recent purchase price of glycine has indeed dropped significantly, but the purchase price of yellow phosphorus has obviously repeated recently after the previous decline. At present, the cost of glyphosate in the company remains relatively stable and the profitability is generally good. As the company mainly exports and mainly settles in US dollars, it did have a positive impact on the company’s operating performance at the moment when the RMB depreciated against the US dollar. By the end of half a year, the accumulated exchange gains and losses were about 40 million yuan.

  Q: When will the 20,000-ton high-performance silicone material project in Xin ‘an Mai Tu, the 100,000-ton silicon powder in Xiexin Leshan, the first phase of western Xinyu pesticide, the 50-ton silicone rubber and 10-ton electronic potting adhesive in Qingyuan, Guangdong, the 30-ton photovoltaic adhesive, the flame retardant project in Xin ‘an, Fujian, the 30,000-ton photovoltaic adhesive project added by Lide and the Zijin Liyuan Ferrous lithium phosphate project all be put into production?

  A: The 52,000-ton high-performance silicone material project in Xin ‘an Mai Tu has been put into production. The Xiexin Leshan silicon powder project will be completed and put into operation in the first half of 2023, and the first phase of the western Xinyu selective herbicide project will be put into operation at the end of this year. Xin’ an Tianyu new project is currently in the preliminary preparation process and has not yet started construction. The first phase of Fujian Xin ‘an Flame Retardant Project will be completed and put into operation in the middle of next year. Lide’s 30,000-ton photovoltaic rubber project has entered the stage of equipment procurement, and it is planned to be put into production at the end of this year and early next year. Zijin Lithium Yuan Ferrous lithium phosphate Project is scheduled to be completed and put into operation in the first half of next year.

  Q: Please tell us about the company’s current production capacity and layout of industrial silicon, especially the Yunnan Yanjin project. Besides self-use, how much production capacity does the company currently sell to the outside world every month? Thank you.

  A: The company’s current production capacity is mainly concentrated in Yunnan, Sichuan and Heilongjiang, with an existing production capacity of about 150,000 tons. The Yanjin project in Yunnan is still under construction. At present, the self-produced industrial silicon is mainly used for the production of silicone products for personal use.

  Q: Are most of the equipment in the relocation project of the civilized industrial park of the company repurchased or reused? Does the government compensate for the relocation expenses incurred? What are the plans for the idle plots in the old park after the relocation? After the relocation, what is the difference between the new park and the old park in terms of production capacity?

  A: Kaihua () Park is mainly for newly-built production capacity, and all facilities and equipment have been redesigned and constructed. The government will give some relocation compensation, and the land in the old park will be returned to the government after relocation. The new park plans a 300,000-ton special silicone material project, which greatly improves the original production capacity and varieties.

  The main business of Xin ‘an Co., Ltd.: development, production and sales of high-efficiency and low-toxicity pesticide products such as glyphosate and chlorpyrifos; Development, production and operation of silicone monomer and its downstream products; Development, production and operation of fine and biochemical products and provision of transportation services.

  The 2022 interim report of Xin ‘an Co., Ltd. shows that the company’s main income is 13.343 billion yuan, up 57.72% year-on-year; The net profit of returning to the mother was 2.334 billion yuan, up 181.69% year-on-year; Deducted non-net profit was 2.322 billion yuan, up 181.32% year-on-year; In the second quarter of 2022, the company’s main revenue in a single quarter was 6.841 billion yuan, up 46.98% year-on-year; The net profit returned to the mother in a single quarter was 1.108 billion yuan, up 102.28% year-on-year; Non-net profit deducted in a single quarter was 1.109 billion yuan, up 102.95% year-on-year; The debt ratio is 39.66%, the investment income is 71.8545 million yuan, the financial expenses are-34.7922 million yuan, and the gross profit margin is 27.02%.

  In the last 90 days, the stock has been rated by 3 institutions and 3 buy ratings; The average institutional target price in the past 90 days is 30.2.

  The following is the detailed profit forecast information:

  The data of margin financing and securities lending show that the stock has a net inflow of 163 million in the past three months, and the financing balance has increased; The net inflow of securities lending was 12.5678 million, and the balance of securities lending increased. According to the financial report data in the past five years, the Securities Star valuation analysis tool shows that the moat of competitiveness in Xin ‘an stock industry is good, its profitability is good, and its revenue growth is average. Financial health. The stock has a good company index of 3.5 stars, a good price index of 3.5 stars and a comprehensive index of 3.5 stars. (The index is for reference only, and the index range is 0~5 stars, with a maximum of 5 stars)

  Chengdu Pioneer: A performance briefing will be held on September 2nd.

  On September 6, 2022, Chengdu Pioneer announced that the company held a performance briefing on September 2, 2022, and investors who participated in the company’s semi-annual performance briefing in 2022 participated through the online platform of "SSE Roadshow Center".

  The details are as follows:

  Q: Why did the company’s financial expenses change so much in the first half of the year?

  A: Hello, thank you for your attention to the company! The decrease of the company’s financial expenses in the first half of the year is mainly due to the increase of exchange income caused by the change of foreign currency exchange rate in this period. Thank you!

  Q: How was the domestic market development in the first half of the year?

  A: Hello, thank you for your attention to the company! In view of the diversified needs of domestic customers, the company actively promotes various services related to new drug research and development and promotes the external transfer of self-developed new drug projects in combination with the company’s four core technology platforms and one-stop service capabilities for preclinical drug research and development. In the first half of the year, the income of domestic customers of the company was 28,355,800 yuan, a year-on-year increase of 25.42%, accounting for 20.44% of the operating income.

  Q: What are the reasons for the performance changes in the first half of the year and what are the solutions?

  A: Hello, thank you for your attention to the company! The main reasons for the performance changes in the first half of 2022 are as follows

  1. The revenue of DEL customized library and screening service decreased year-on-year. DEL customized library service mainly provides customized DN-coded compound library design and synthesis services for global innovative pharmaceutical R&D and production enterprises (mainly large multinational pharmaceutical companies), helping the other party to provide early R&D basic platform construction. This type of business has the characteristics of large single order amount, long contract negotiation cycle and execution cycle. With the wide application of DEL technology, the company’s DEL screening service is in a period of upgrading and transformation. In addition to large multinational pharmaceutical companies, the customer base has gradually expanded to biotechnology companies, chemical companies, foundations and scientific research institutions. Different from large multinational pharmaceutical companies covering multiple targets under the same order, the overall order amount is large, and some small or start-up biotechnology companies or scientific research institutions may screen targets in a special field, covering fewer targets, and the single order amount is relatively small.

  2. The gross profit margin of some businesses such as customized development services for new drugs decreased. Based on the new drug project, the company provides one-stop new drug customization service for domestic customers. This kind of business usually has a large contract order amount and a long execution period, and has the characteristics of early new drug project research and development, that is, the degree of customization is high, and the development difficulty, time period, cost and success rate of each stage of project implementation are different. During the reporting period, the customized development project of new drugs was still in the early research stage, and at the same time, it had different implementation stages and different development difficulties compared with the comparable period, so the gross profit margin decreased. In addition, affected by the rising unit price of raw materials, the gross profit margin of related businesses with a relatively large proportion of raw materials in the cost decreased to some extent during the reporting period.

  At present, the company is actively taking various countermeasures, such as continuing the order of customized libraries for existing customers, adding small customized libraries or characteristic customized libraries and other business models suitable for a wider customer base, and launching OpenDEL? Related business supplements its vacancy in the small-scale DEL library customization business market. At the same time, the company is increasing the construction of business team to actively expand customers with DEL screening service needs for different target types.

  Q: Is there any separation between the company’s self-research projects and customers’ projects? Will there be any intellectual property disputes in the future?

  A: Hello, thank you for your attention to the company! Intellectual property related to drug structure is the core IP of innovative drugs. In order to ensure that there is no conflict of interest between the company’s new drug research and development projects and customer screening projects, the company strictly abides by the principles of target exclusion and molecular structure exclusion in its business model. The original ownership of the compound structure in the company’s drug discovery platform belongs to the company. After the effective emerging compounds are found in the screening service mode or the new drugs independently developed are promoted to a certain extent, the company transfers the intellectual property rights related to the compound structure or the development and commercialization rights to the customers by signing an authorization and transfer agreement with the customers.

  First, the principle of target exclusion. The company accepts the client’s entrustment of screening projects on the basis of targets. Once the client determines a screening target, it will have a certain exclusion period (usually 3 years, which is subject to the contract). During the exclusion period, the company will not accept other clients’ entrustment of screening services for the same target, nor will it screen independent new drug projects for this target.

  Second, the exclusive principle of molecular structure. By signing a transfer and authorization agreement with customers, the company permanently and exclusively transfers the intellectual property rights of molecular structure to customers. Even if the molecule shows good drug-forming properties to other targets in the subsequent research and development process, it cannot be transferred and developed because of the exclusive mechanism. The implementation of the two exclusive principles ensures that there is no conflict of interest between the company’s new drug R&D project and the customer screening project, and between the projects of different customers, thus gaining great trust and recognition from customers at home and abroad, enabling the company’s unique model of "new drug R&D service+rights transfer of new drug research projects" to be carried out smoothly and maintaining a good reputation in the international pharmaceutical industry. thank you

  Q: What caused the change of net cash flow generated by the company’s operating activities in the first half of the year?

  A: Hello, thank you for your attention to the company! The change of net cash flow generated by the company’s operating activities in the first half of the year was mainly caused by the decrease of sales income in the current period and the increase of cash paid for goods and services. thank you

  Q: What is the difference between your company’s DEL technology and other companies’ DEL technology?

  A: Hello, thank you for your attention to the company! Chengdu Pilot DEL technology has the following advantages and advantages.

  First of all, the scale of molecular library that DEL library can achieve in design and synthesis has developed by leaps and bounds compared with the traditional one, which can reach trillions of solid molecular libraries (the number of traditional solid molecular libraries is generally in the millions);

  Secondly, in terms of synthesis time and cost, using DEL library technology can build a large-scale molecular library resource with better diversity within a few years at a lower cost, while using traditional technology requires huge investment (about hundreds of millions of dollars) and years or even decades to accumulate;

  Thirdly, because all the compounds have DN codes, it is possible to confirm the chemical structure from the huge mixture signal by DN sequencing, and hundreds of billions or even trillions of compounds can be screened in the mixture, which is more efficient than the traditional lead compound discovery method (the traditional screening can only achieve millions of molecular screening due to the limitation of cost and technology);

  Fourthly, due to the introduction of DN tag, hundreds of billions of compounds can form a mixture for one-time screening, which makes the molecular dosage required for screening extremely small, so the relative cost is extremely small;

  Fifth, compared with SBDD, CDD and virtual screening technology, DEL technology can quickly screen emerging compounds and find new molecules that may become drugs even in the face of new targets and targets that lack target structure information and/or ligand reference information, and has wide applicability; And because a large number of compounds can be screened each time, the screening results can provide a large number of experimental results data for these technologies and accelerate the development of such technologies;

  Sixth, the number of academic papers related to DEL library chemistry published by Chengdu Pioneer is among the best, which reflects the company’s advanced nature and high quality in improving library chemistry and provides basic support for molecular diversity;

  Seventh, by the end of the reporting period, the company has accumulated rich experience in screening more than 51 target types and hundreds of targets, and achieved a screening success rate of nearly 80% in project synthesis;

  Eighth, the successful application of different molecular types in target screening, such as small molecular compound library, macrocyclic compound library, covalent compound library, protein degradation compound library, molecular fragment compound library, etc., has expanded the scope of molecular types and drug targets.

  Moreover, Chengdu Pioneer is the only growing biotechnology company with internationally leading DEL technology and FBDD/SBDD technology in the field of drug discovery. At the same time, the company also has two emerging technology platforms, namely, the technology platform related to research and development of new nucleic acid drugs (STO) and the technology platform related to targeted protein degradation (TPD), which has formed obvious differentiated competitive advantages and technical barriers with other biotechnology companies and CRO companies in the field of drug discovery.

  Q: The British company you bought is also losing money when you read the semi-annual report. Please, what is the reason?

  A: Hello, thank you for your attention to the company! Vernalis’s main business model is customized development service of new drugs based on its FBDD/SBDD core technology. This kind of business usually has a large overall order amount and a long execution cycle, and the contract stipulates that it will be carried out in stages with the progress of project research and development. During this period, Vernalis will receive the service consideration paid by customers in FTE mode, and after reaching certain key conditions in each stage, it will correspondingly receive milestone income. For example, in 2021, Vernalis obtained the pre-clinical milestone fee from Servier. The rights and interests of new drug projects in this kind of contract belong to the customer, and at the same time, the uncertain risk of R&D failure is also borne by the customer. At the same time, Vernalis’s customers are mostly perennial partners. The company acquired Vernalis in order to obtain technical and commercial synergies from the group level, thus enhancing the overall room for subsequent growth. thank you

  Q: The company’s DEL database building and DEL screening capabilities are well-known in the world, and this part of the business is mainly American customers. Will the company consider establishing a small R&D team and BD team in the United States to smoothly meet the needs of customers, rather than passively waiting because of the impact of the epidemic?

  A: Hello, thank you for your advice! The company has established a subsidiary in the United States, Delaware, which is responsible for technology research and development and business development. According to the current and subsequent environmental situation, the company will consider whether to expand the R&D team and business team in the United States. thank you

  Q: What is the current quantity and quality of DEL molecular library?

  A: Hello, thank you for your attention to the company! By the end of the reporting period, the number of DEL library molecules of the company has exceeded 1.2 trillion, which is the largest and largest solid small molecule compound library in the world. At the same time, through the systematic design of library molecules, the company has added more than 6,000 kinds of synthetic molecular skeletons, basically covering the core skeletons of all small molecular drugs that have been approved for marketing at present, as well as most dominant skeletons of small molecular projects under clinical research, with nearly 40,000 kinds of synthetic building blocks.

  Chengdu Pioneer’s main business: using its core technology DEL technology to provide research and development services in the early stage of drug discovery and transfer of new drug research and development projects.

  Chengdu Pioneer 2022 reported that the company’s main income was 139 million yuan, down 10.01% year-on-year; The net profit of returning to the mother was-7,058,100 yuan, a year-on-year decrease of 134.17%; Deducting non-net profit-12.2615 million yuan, down 204.55% year-on-year; In the second quarter of 2022, the company’s main income in a single quarter was 66.2504 million yuan, down 22.03% year-on-year; The net profit returned to the mother in a single quarter was 30,400 yuan, down 99.8% year-on-year; Non-net profit deducted in a single quarter was-1,873,700 yuan, a year-on-year decrease of 121.12%; The debt ratio is 23.05%, the investment income is 9,645,500 yuan, the financial expenses are-10,596,200 yuan, and the gross profit margin is 37.15%.

  In the last 90 days, the stock has been rated by 2 institutions and 2 buy ratings; The average institutional target price in the past 90 days was 18.9.

  The following is the detailed profit forecast information:

  The data of margin financing and securities lending shows that the net financing outflow of the stock in the past three months is 17.9925 million, and the financing balance is reduced; The net inflow of securities lending was 1,905,900, and the balance of securities lending increased. According to the financial report data in recent five years, the Securities Star valuation analysis tool shows that the moat of competitiveness in Chengdu’s leading industry is good, with good profitability and good revenue growth. There may be hidden troubles in finance, and the financial indicators that should be focused on include: accounts receivable/profit rate, the increase of accounts receivable/profit rate in the past three years, and operating cash flow/profit rate. The stock has a good company index of 3 stars, a good price index of 2 stars and a comprehensive index of 2.5 stars. (The index is for reference only, and the index range is 0~5 stars, with a maximum of 5 stars)

  Semi-annual equity distribution of Shimao Energy: 0.2 yuan registered its equity on September 14th for each share.

  () Announced that the company’s equity distribution in the first half of 2022 will be implemented: based on the company’s total share capital before the implementation of the plan, cash dividends will be distributed to each share, with 0.2 yuan (including tax), date of record on September 14th, 2022 and ex-dividend date on September 15th, 2022.

  Mubang Hi-Tech plans to borrow 450 million yuan from the controlling shareholder.

  On the evening of September 6th, () announced that the company intends to borrow money from Shantou Bangling Trading Co., Ltd. (hereinafter referred to as "Bangling Trading"), the loan amount does not exceed 450 million yuan, and the loan period is 12 months. Within this amount and period, the company can use it in a rolling way. The loan interest rate is not higher than the loan interest rate announced by the one-year commercial bank for the same period.

  Mubang Hi-Tech said that this loan from Bangling Trade is to broaden the sources of funds and promote the construction and development of the company’s business, which is conducive to the company’s sustained and stable operation, in line with the interests of the company and all shareholders, and will not adversely affect the company’s future financial situation and operating results.

  Ou Ke billion granted 310,000 restricted shares to the incentive object.

  Ou Ke Billion announced that the company held a meeting on September 6, 2022, and deliberated and passed the Proposal on Granting Reserved Restricted Shares to Incentive Objects. It was determined that the reserved grant date of this incentive plan was September 6, 2022, and 310,000 restricted shares were granted to four eligible incentive objects at the grant price of 27.60 yuan per share.

  Jiaao Environmental Protection: It is planned to invest 4 billion yuan to build a bio-jet fuel project with an annual output of 500,000 tons.

  Jiaao Environmental Protection announced on the evening of September 6 that the company plans to implement a project with an annual output of 500,000 tons of bio-jet fuel in Lingang Industrial Zone, Guanyun County, Lianyungang City, and the project is scheduled to start construction in January 2023. The total planned investment of this project is 4 billion yuan, mainly from self-raised funds and financing. The products of the project are new biomass energy such as bio-jet fuel, and the raw materials are waste animal and vegetable oils. The production of this product has positive significance for reducing carbon emissions.

  Botuo Bio’s two detection reagent products obtained the domestic medical device registration certificate.

  Botuo Bio announced that two products of the company have recently obtained the People’s Republic of China (PRC) Medical Device Registration Certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration (NMPA), namely "Detection reagent for histidine-rich protein II(HRP-II) of Plasmodium falciparum (colloidal gold method)" and "Detection reagent for NS1 antigen of dengue virus (colloidal gold method)".

  City Investment Holdings: Vice Chairman Chen Shuai resigned.

  () Announcement, the board of directors of the company recently received a written resignation report from Vice Chairman Chen Shuai. For personal reasons, Chen Shuai resigned from the board of directors as the vice chairman, director, member of the strategy committee and member of the remuneration and assessment committee of the 10th board of directors of the company.

  Weiming Environmental Protection: Invest in high matte nickel projects and sign joint venture agreements.

  () Announcement, Weiming (Hong Kong) International Holdings Co., Ltd., a wholly-owned subsidiary of the company, signed the Joint Venture Agreement on the Project of 50,000 Tons of Nickel-containing High-matte Nickel (Indonesia) with Merit, GEM Hong Kong and Weiming for investment in the construction of high-matte nickel project, with a total investment of no more than 448 million US dollars.

  Baosteel packaging: Changxia Jinshi and its concerted actions reduced their holdings by 1.01%.

  () Announcement was issued. On September 6, 2022, the company received the Letter of Notice on the Progress of Share Reduction issued by its shareholder Changxia Jinshi (Wuhan) Equity Investment Fund Partnership (Limited Partnership) and its concerted action partner Anhui Jiaokong Jinshi M&A Fund Partnership (Limited Partnership) ("Anhui Jiaokong Jinshi"). The above shareholders reduced their holdings by 11,427,500 shares this time, with a reduction ratio of 1.01%.

  Sichuan Investment Energy: All power stations of Sichuan Investment Power are in good working condition.

  The financial sector announced on September 6th that the dam surface of Renzonghai Reservoir of Tianwanhe Company was not damaged, and the generator sets of Renzonghai Power Station, Jinwo Power Station and Daji Power Station were not damaged. All power stations of Sichuan Investment Power are in good working condition, running safely and stably, and are doing their best to ensure power supply; The earthquake did not affect and cause losses to the construction of Panzhihua hydropower project, and the project safety was under control, and the project construction quickly returned to normal order.

  Shenkeda: use the funds raised by "Shenke Convertible Bonds" to replace the self-raised funds that have been put into the fundraising projects in advance and paid the issuance fees.

  On September 6, the financial sector announced that Shenkeda intends to use the funds raised by "Shenke Convertible Bonds" to replace the self-raised funds of 53,157,800 yuan that have been invested in fundraising projects in advance and paid the issuance fees. The replacement time of the company’s raised funds is less than 6 months from the time when the raised funds are received, which is in line with the requirements of relevant laws and regulations.

  The GDR application of Guolian shares was accepted by China Securities Regulatory Commission.

  () Announcement. Recently, the company received the Acceptance Form for Administrative License Application of China Securities Regulatory Commission (acceptance number: 222073) issued by China Securities Regulatory Commission (hereinafter referred to as "China Securities Regulatory Commission") on September 2, 2022, and the China Securities Regulatory Commission submitted to the company that the company intends to issue Global Depositary Receipts ("GDR") and list it on the Swiss Stock Exchange (hereinafter referred to as "GDR")

  De Fengjie, shareholder of Haitai Xinguang, reduced his shareholding by 1.06%.

  Haitai Xinguang announced that on September 6, 2022, the company received the Notice on Reducing Shares by More than 1% from the company’s shareholder Shanghai Defengjie Longsheng Venture Capital Partnership (Limited Partnership) (hereinafter referred to as "Defengjie") and its concerted parties, and the shareholder Defengjie reduced its shares by 923,000 shares, accounting for 1.0611% of the company’s total share capital.

  Guisheng Co., Ltd. has no plans to engage in wine-related business, and the rumors about "liquor companies borrowing from the back door" are not true.

  () It was announced that the company’s stock increased by 154.04% from July 13, 2022 to September 6, 2022, and the company’s stock price increased greatly in the short term. The company’s P/E ratio and P/B ratio have been significantly higher than the industry level.

  As of the announcement date, the company’s production and operation are normal. The company is not involved in the negotiation or negotiation of "backdoor" and "reorganization" with wine enterprises, and has no plans to engage in wine-related business. The rumors about the company’s "backdoor" of wine enterprises are not true.

  China grand auto: Bao Xiangyi succeeded Wang Xinming as president of the company.

  () Announcement: Recently, the board of directors of the company received a written resignation application from Wang Xinming, the president of the company. Wang Xinming applied to resign as the president of the company for personal reasons, and his resignation report will take effect as of the date of delivery to the board of directors of the company. After resigning, Wang Xinming did not hold other positions in the company. In addition, on September 6, 2022, the board of directors of the company reviewed and approved the Proposal on Appointing the President of the Company and agreed to elect Bao Xiangyi as the President of the Company.

  China grand auto set up brand division.

  China grand auto announced that in order to actively build a management system that meets the requirements of the company’s development strategy, better integrate resources, optimize management efficiency and improve the company’s refined management level, the board of directors of the company reviewed and approved the Proposal on Adjusting the Company’s Organizational Structure on September 6, 2022. Based on the existing organizational structure of regional management, the company further strengthened brand management, set up a brand division and adjusted its internal organizational structure accordingly.

  Weiming Environmental Protection plans to build a project with an annual output of 50,000 tons of nickel-bearing metal with high matte content in Indonesia together with Gemei Hong Kong.

  Weiming Environmental Protection announced that on September 6, 2022, Weiming (Hong Kong) International Holdings Co., Ltd. ("Weiming Hong Kong Company" or "Weiming"), Merit International Capital Limited (hereinafter referred to as "Merit Company") and Gemei Hong Kong International Logistics Co., Ltd. (hereinafter referred to as "Gemei Hong Kong") signed the "About Merit, Gemei Hong Kong and High-matte Nickel Project"

  It is reported that the company plans to establish a joint venture with Merit and Gemme Hong Kong. The tentative English name of the project company is PT JIAMANMEI NEW ENERGY, and the tentative Chinese name is Jiamanmei New Energy Co., Ltd.; Address: Jakarta, Indonesia. The authorized capital of the project company is US$ 1 million, with Weiming Hong Kong holding 51%, Merit holding 26% and GEM Hong Kong holding 23%.

  According to the announcement, the high matte nickel project is planned to produce 50,000 tons of high matte nickel-containing metal annually, which is located in the Weda Bay Industrial Park (IWIP) in halmahera island, with a total investment of no more than 448 million US dollars. According to the company’s share ratio, the company’s investment in the project company this time with its own funds does not exceed 69 million US dollars. 30% of the total investment of the project shall be provided by the parties to the agreement with their own funds according to the proportion of their shares in the joint venture company, and 70% of the total investment of the project shall be financed by Weiming with the joint venture company as the borrower, and all parties to the agreement shall actively cooperate.

  Zhongkong Zhilian: Announcement on Continued Suspension of Stock Trading

  On September 6, 2022, Zhongkong Zhilian announced that due to the uncertainty of related matters, the company’s stock will continue to be suspended and it is expected to resume trading before September 9, 2022.

  Financial Tips: According to public data, the operating income of Zhongkong Zhilian in 2021 was 1,148,058 yuan, the net profit attributable to the parent company was-585,056 yuan, the return on net assets was -10.07%, and the growth rate of operating income was null%. At present, the sponsoring brokerage firm is () Co., Ltd., and the trading method is call auction trading, which belongs to the basic level.

  Saifutian has spent 32,270,300 yuan to repurchase 3,789,600 shares.

  () Announcement was issued. As of August 31st, 2022, the company has repurchased 3,789,600 shares through centralized bidding, accounting for 1.32% of the company’s total share capital. The highest repurchase price is 10.00 yuan/share, and the lowest is 7.49 yuan/share, with a total transaction amount of 32,270,300 yuan (excluding transaction costs).

  Weiming Environmental Protection: Signing a joint venture agreement to invest in high matte nickel projects.

  Weiming Environmental Protection announced on the evening of September 6th that Weiming Hong Kong, a wholly-owned subsidiary of Weiming Hong Kong, signed a joint venture agreement with Merit Company and Gemei Hong Kong to invest in the construction of high matte nickel project with an annual output of 50,000 tons of nickel-containing metal (Indonesia). The company plans to invest and build a high matte nickel project through its subsidiaries, with an annual output of 50,000 tons of high matte nickel-containing metal, and the total investment of the project does not exceed 448 million US dollars. The company’s investment in the project company does not exceed USD 69 million.

  Guolian shares: the application for issuing GDR was accepted by China Securities Regulatory Commission.

  On the evening of September 6th, Guolian announced that the company’s application for issuing global depositary receipts (GDR) and listing on the Swiss Stock Exchange was accepted by the China Securities Regulatory Commission.

  Hainan Rubber received compensation of 20.18 million yuan from rubber income insurance.

  () Announcement, according to the Insurance Agreement of Hainan Rubber Income Insurance Project in 2021 signed by the company with China People’s Property Insurance Co., Ltd. and China Pacific Property Insurance Co., Ltd., the insurance compensation conditions were triggered by pests and diseases during April-May 2022, and the amount of insurance compensation was determined to be 20,181,100 yuan through three-party investigation and loss determination. Recently, the company has received the above compensation, and the accounting is included in other income.

  Jinhong Gas and Zhongneng Silicon Industry reached a strategic cooperation on jointly promoting silane gas sales and other fields.

  Jinhong Gas announced that based on the principles of equality, mutual benefit, resource sharing, complementary advantages and win-win cooperation, the company and Jiangsu Zhongneng Silicon Industry Technology Development Co., Ltd. ("Zhongneng Silicon Industry", GCL Photovoltaic Power Technology Holdings Co., Ltd. holds 64.16% and Fuduo International Development Co., Ltd. holds 35.84%) reached a strategic cooperation intention through friendly negotiation and recently signed the Strategic Cooperation Framework Agreement.

  It is reported that the agreement is a strategic agreement reached by both parties through friendly negotiation, and does not involve specific content and amount. The two parties have established a strategic partnership, aiming at jointly promoting cooperation in silane gas sales and other fields through close cooperation and creating better economic and social benefits for both parties.

  Leran Technology, the shareholder of Sirui New Materials, has increased its holdings by a total of 2,982,900 yuan, and the implementation of the increase has been completed.

  Sirui New Materials announced that as of the disclosure date of this announcement, Shenzhen Leran Technology Development Co., Ltd. increased its holding of 257,600 shares by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for 0.06% of the company’s total share capital, with a total holding amount of 2,982,900 yuan (including various taxes), and this holding plan has been implemented.

  Jinhong Gas: Signed a strategic cooperation framework agreement with Zhongneng Silicon Industry.

  Jinhong Gas announced on the evening of September 6 that the company signed a strategic cooperation framework agreement with Jiangsu Zhongneng Silicon Industry Technology Development Co., Ltd. to establish a strategic partnership on silane gas sales. Zhongneng Silicon Industry is responsible for producing and filling silane gas that meets the technical specifications and quality agreed by both parties, and the company purchases silane gas from it.

  Two-board Vico technology: At present, there is no sodium battery related business in the company.

  () Announcement of changes was issued. Recently, the company paid attention to the rumors about Vico Technology investing in sodium batteries in the market. In response to the rumors, the following explanations are made: the company’s main business has not changed, and the company does not have any sodium battery related business at present.

  1,747,900 restricted shares of Sirui New Materials were listed and circulated on September 16th.

  Sirui New Materials announced that the number of shares that the company lifted the restriction on sales and applied for listing and circulation was 1,747,900. Now the lock-up period is about to expire and it will be listed and circulated on September 16, 2022.

  Wu Yongli, supervisor of power source, intends to reduce his holdings by no more than 105,700 shares.

  Power source announced that due to personal capital demand, Mr. Wu Yongli, the supervisor, intends to reduce the company’s shares by no more than 105,700 shares by centralized bidding, accounting for 0.02% of the company’s total share capital.

  *ST Garden City once again postponed the reply to the supervisory inquiry letter of the Shanghai Stock Exchange on the company’s 2021 annual report.

  On the evening of September 6th, () announced that some issues involved in the Inquiry Letter on Information Disclosure Supervision of Yantai Yuancheng Gold Co., Ltd. 2021 Annual Report (hereinafter referred to as "Inquiry Letter on Supervision") still need to be further supplemented and improved, and the company is not expected to complete the reply within the specified time, so the company will postpone the reply for another five trading days to coordinate and promote the completion of the reply, and fulfill its information disclosure obligations in a timely manner as required.

  It is understood that *ST Garden City received the "Regulatory Inquiry Letter" issued by the Management Department II of listed companies on the Shanghai Stock Exchange on April 22, requiring the company to reply within 5 trading days. It has been more than 4 months since then, and after more than ten delays, *ST Garden City has still failed to reply.

  There is no sodium battery related business in Vico Technology at present.

  Vico Technology announced that the closing price of the company’s shares deviated by more than 20% in three consecutive trading days on September 2, September 5 and September 6. According to the relevant provisions of the Trading Rules of Shanghai Stock Exchange, the company’s stock trading is in an abnormal fluctuation situation.

  Recently, the company paid attention to the rumors that Vico Technology invested in sodium batteries in the market. In response to the rumors, it is now explained as follows: the company’s main business has not changed, and there is no sodium battery related business in the company at present.

  Confirmed by the company’s self-examination and consultation with the controlling shareholder and actual controller: As of the disclosure date of this announcement, there are no significant matters or information that should be disclosed but not disclosed by the company, controlling shareholder and actual controller.

  Jianlong Weina donated 500,000 yuan to Sichuan earthquake-stricken area.

  Jianlong Weina announced that the company donated 500,000 yuan to Sichuan earthquake-stricken area through Luoyang Charity Federation for earthquake emergency rescue, transitional resettlement and post-disaster reconstruction.

  Xingfa Group: It is planned to invest in electronic adhesive products with Xinya Process.

  Xingfa Group announced that the company signed a cooperation framework agreement with Xinya Process, and both parties will invest to set up a new company in Xiaoting District, Yichang City. After the establishment of the new company, it will devote itself to the research, development, production and sales of electronic adhesive products, and build 30,000 tons/year of electronic adhesive products in the first phase.

  Anhui Venture Capital, the shareholder of Wanyi Technology, plans to reduce its holdings by no more than 1,337,700 shares.

  Wanyi Technology announced that the company received the Notice Letter on the Stock Reduction Plan issued by Anhui Venture Capital on September 6, 2022, and Anhui Venture Capital reduced the number of shares held by the company by centralized bidding from September 29, 2022 to December 31, 2022, with a reduction ratio of no more than 1,337,700 shares.

  Zhewen Film Industry: It is planned to list some properties of its subsidiaries for sale.

  Zhewen Film announced that the company intends to sell the office building of Century Changlong, a wholly-owned subsidiary, located in Building 12, Zone G, Gulou District Software Park, Fuzhou City, Fujian Province, at a listing price of not less than 33,331,700 yuan. If the above assets are sold at the listing price, the transaction is expected to affect the net profit attributable to shareholders of the listed company by about 15 million yuan.

  Xinqianglian and Mingyang Intelligent reached a strategic cooperation in the fields of bearing design and development of new fans.

  () Announcement: Recently, the company and Mingyang Smart Energy Group Co., Ltd. (() ",601615.SH) signed the Strategic Cooperation Framework Agreement. Through close cooperation between the two parties, we will build a win-win and sustainable strategic partnership and jointly promote all-round cooperation in the design and development of main shaft bearings and yaw pitch bearings of new wind turbines and the development and application of new technologies.

  Xinqianglian: Signing a strategic cooperation framework agreement with Mingyang Intelligent.

  Xinqianglian announced on the evening of September 6 that the company signed a strategic cooperation framework agreement with Mingyang Intelligent to jointly promote the comprehensive cooperation between the two sides in the design and development of main shaft bearings and yaw pitch bearings of new wind turbines and the development and application of new technologies.

  Wanyi Technology: Anhui Venture Capital intends to reduce its shareholding by no more than 1%.

  Wanyi Technology announced on the evening of September 6 that Anhui Venture Capital, a shareholder holding 5.53%, intends to reduce its shareholding by no more than 1%.

  Delong Laser intends to subscribe for fund shares to invest in new materials, high-end equipment, digital technology and other industries.

  Delong Laser announced that the company plans to invest 30 million yuan with its own funds to subscribe for 4.8687% of the subscribed capital of Suzhou Woyan Green Specialization Venture Capital Partnership (Limited Partnership) ("Suzhou Woyan"). After the completion of this round of fundraising, the total subscribed capital of Suzhou Woyan is 616.18 million yuan. Suzhou Woyan focuses on investing in high-quality unlisted growth enterprises in new materials, high-end equipment and digital technology-related industries.

  () 20.41 million restricted shares were granted to the incentive object for the first time at a grant price of 6.95 yuan/share.

  Ningbo Yunsheng announced that the company held the 12th meeting of the 10th Board of Directors on September 6th, 2022, and deliberated and passed the Proposal on Granting Restricted Stock to the Incentives of the Restricted Stock Incentive Plan in 2022 for the first time. According to the authorization of the second extraordinary shareholders’ meeting in 2022, the board of directors of the company considered that the conditions for the first grant of the restricted stock incentive plan in 2022 had been achieved, and agreed to set September 6th, 2022 as the first grant date to eligible 2022.

  Jiaao Environmental Protection: It is planned to invest in new biomass energy and new biomass materials projects.

  Jiaao Environmental Protection Announcement, the company plans to sign the Project Cooperation Agreement with Guanyun County Government, and the company plans to invest in new biomass energy and new biomass materials projects in the Lingang Industrial Zone of Guanyun County. The new biomass energy project with a capacity of 1 million tons/year of bio-jet coal will be built in two phases, of which the first phase plans to invest about 4 billion yuan to build a 500,000-ton/year bio-jet coal project, which is scheduled to start construction in January 2023.

  Weiming Environmental Protection: It is planned to jointly invest in a project with an annual output of 50,000 tons of nickel-bearing metal with high matte content.

  Weiming Environmental Protection announced that Weiming Hong Kong Company, a wholly-owned subsidiary of the company, signed a joint venture agreement with Merit Company and GEM Hong Kong to produce 50,000 tons of nickel-containing metal with high matte annually (Indonesia). The company plans to set up a joint venture with Merit Company and GEM Hong Kong to build a project company with an annual output of 50,000 tons of nickel-containing metal with a total investment of no more than 448 million US dollars. This time, the company’s investment in the project company with its own funds does not exceed USD 69 million.

  Liu Kuanqing, a shareholder of Huatong Cable, plans to reduce its shareholding by no more than 3%.

  () Announcement: Due to shareholders’ own capital needs, Liu Kuanqing, Zhang Huizhi, Ningbo Zeliantong and Ningbo Zewang intend to reduce their shares in the company by centralized bidding within three months after 15 trading days from the date of the announcement of the company’s reduction plan, with a total reduction of no more than 5,068,200 shares and a total reduction of no more than 1.00% of the company’s total share capital, and a total reduction of no more than 10,136,400 shares by block trading.

  Tianqi Co., Ltd. and Jinghe Shaanxi Coal Research Institute reached a strategic cooperation to lock in the raw material resources of waste lithium batteries.

  () Announcement: Recently, the company signed the Strategic Cooperation Framework Agreement with New Energy Materials Co., Ltd. of Jinghe New City Shaanxi Coal Technology Research Institute ("Jinghe Shaanxi Coal Research Institute"), and the two parties intend to cooperate in the field of lithium-ion battery core materials, waste power batteries and battery waste recycling, and jointly build a closed-loop industrial chain for recycling waste power batteries.

  It is reported that Jinghe Shaanxi Coal Research Institute is a wholly-owned subsidiary of Shaanxi Coal Chemical Technology Research Institute ("Shaanxi Coal Research Institute"), a wholly-owned subsidiary of () Chemical Group Co., Ltd. ("Shaanxi Coal Group"). It is planned to be a research and development, test and demonstration production base for Shaanxi Coal Research Institute to realize industrialization in China with advanced technologies in the direction of independent innovation of new energy materials. The planned main products and businesses cover nickel ternary precursor materials, lithium phosphate precursors and their cathode materials, etc.

  The announcement shows that this cooperation will help the company to further lock in the raw material resources of waste lithium batteries, provide continuous and stable raw material guarantee for the company’s lithium battery recycling business, and further strengthen the core competitiveness of the company’s lithium battery recycling business. In addition, based on the friendly cooperation between the two parties, the company and Jinghe Shaanxi Coal Research Institute will further jointly build a ternary precursor production line.

  Huatong Cable: Shareholders intend to reduce their holdings by no more than 3% in total.

  Huatong Cable announced on the evening of September 6th that the company’s shareholder Liu Kuanqing and his concerted action Zhang Huizhi, Zeliantong Equity Investment Partnership (Limited Partnership) in Ningbo Meishan Bonded Port Area and Zewang Equity Investment Partnership (Limited Partnership) in Ningbo Meishan Bonded Port Area intend to reduce their shares by no more than 3% of the company’s total share capital.

  Huayang new materials: 60,000 tons/year PBAT project of new materials was successfully put into commissioning.

  () On the evening of September 6th, it was announced that the 60,000-ton/year PBAT project began to feed the polymerization unit on September 3rd. At present, the project has been successfully put into trial operation at one time, and qualified products have been produced.

  Huayang New Materials elected Wu Yuehua as the chairman.

  Huayang New Materials announced that on September 6, 2022, the board of directors of the company reviewed and approved the Proposal on Electing the Chairman of the Seventh Board of Directors of the Company, and elected Wu Yuehua as the Chairman of the Seventh Board of Directors of the Company. It is reported that Wu Yuehua is currently a member of the Standing Committee and Director of the Party Committee of Taiyuan Chemical Industry Group Co., Ltd.; Party secretary, director and general manager of the company.

  Huayang New Materials: The "60,000 tons/year PBAT Project of New Materials" was successfully put into trial operation at one time.

  Huayang New Materials announced that since the company’s new material 60,000 tons/year PBAT project started construction last year, the company and the construction party overcame the epidemic situation and completed the installation and commissioning on August 10 this year. On August 22, the heat medium device started to heat up for thermal commissioning, and on September 3, it began to feed the polymerization device. At present, the project has been successfully put into trial operation at one time and produced qualified products.

  The three shareholders of Zhengyuan intend to reduce their holdings by no more than 1.90% in total.

  () It is announced that Hainan Furuiyuan, Hainan Happiness Health and Hainan Happiness Bio plan to reduce their holdings of the company by centralized bidding or block trading, with a total planned reduction of no more than 28.7 million shares, accounting for no more than 1.90% of the company’s total share capital.

  Xinqianglian and Mingyang Intelligent signed a strategic cooperation framework agreement.

  Xinqianglian announced that the company and Mingyang Smart Energy Group Co., Ltd. recently signed the Strategic Cooperation Framework Agreement. Through close cooperation between the two parties, we will build a win-win and sustainable strategic partnership and jointly promote comprehensive cooperation between the two parties in the design and development of main shaft bearings and yaw pitch bearings of new wind turbines and the development and application of new technologies.

  Zhengyuan shares: the concerted action of the controlling shareholder intends to reduce its shareholding by no more than 1.9%.

  Zhengyuan announced on the evening of September 6th that the concerted actions of Hainan Furuiyuan, Hainan Happiness Health and Hainan Happiness Bio, the controlling shareholders of the company, plan to reduce their holdings of the company’s shares by no more than 28,700,500 shares through centralized bidding or block trading, accounting for no more than 1.9% of the company’s total share capital.

  Vico Technology: At present, there is no sodium battery related business in the company.

  Vico Technology released a stock trading announcement. Recently, the company paid attention to rumors about Vico Technology’s investment in sodium batteries in the market. In response to the rumors, the following explanations are made: the company’s main business has not changed, and the company does not have any sodium battery related business at present.

  Jinhong Gas signed a strategic cooperation framework agreement with Zhongneng Silicon Industry.

  Jinhong Gas announced that the company signed a strategic cooperation framework agreement with Jiangsu Zhongneng Silicon Industry Technology Development Co., Ltd. (hereinafter referred to as "Zhongneng Silicon Industry"), and Zhongneng Silicon Industry was responsible for producing and filling silane gas that met the technical specifications and quality agreed by both parties; The company purchased silane gas from Zhongneng Silicon Industry.

  The shareholders of Huatong Cable intend to reduce their holdings by no more than 3% in total.

  Huatong Cable announced that Liu Kuanqing, Zhang Huizhi, Ningbo Zeliantong and Ningbo Zewang intend to reduce their shares by centralized bidding to no more than 1% of the company’s total share capital and by block trading to no more than 2% of the company’s total share capital within 3 months after the announcement of the company’s disclosure of the reduction plan.

  Ruikeda’s shareholder, Guoke Ruihua, reduced its shareholding by 2.16% and its shareholding fell below 5%.

  Ruikeda announced that as of September 6, 2022, Beijing Guoke Ruihua Strategic Emerging Industry Investment Fund (Limited Partnership) ("Guoke Ruihua"), a shareholder of the company, had reduced its shareholding by 2,336,100 shares, accounting for 2.1631% of the company’s total share capital, and the number of reductions had exceeded half. In addition, on September 6, 2022, Guoke Ruihua reduced its holdings by 1,090,100 shares, and after the reduction, it held 5,399,900 shares of the company, accounting for 49,999% of the total shares of the company.

  Rejing Bio plans to buy back 150 million yuan to 300 million yuan, and the repurchase price does not exceed 98.11 yuan/share.

  Rejing Bio announced that the company intends to buy back the RMB ordinary shares (A shares) issued by the company through centralized competitive bidding. The total amount of funds for repurchasing shares is not less than 150 million yuan (inclusive) and not more than 300 million yuan (inclusive), and the price of repurchasing shares is not more than 98.11 yuan/share (inclusive). The time limit for repurchasing shares is within 12 months from the date when the board of directors deliberates and passes this share repurchase plan.

  The controlling shareholder of Zhengyuan Co., Ltd. intends to reduce its holdings by no more than 1.9% in total.

  Zhengyuan shares announced that Hainan Furuiyuan, Hainan Happiness Health and Hainan Happiness Bio, the concerted actions of the company’s controlling shareholders, intend to reduce their shares by no more than 1.90% of the company’s total share capital.

  Hot View Bio: It is planned to buy back shares of RMB 150 million to RMB 300 million.

  Hot View Bio announced on the evening of September 6 that it plans to buy back its shares at a price of 150-300 million yuan, with the repurchase price not exceeding 98.11 yuan/share. The repurchased shares are intended to be used for employee stock ownership plans or equity incentives at an appropriate time in the future.

  Two testing products of Hot Scenery Bio have obtained relevant certification in the UK.

  On September 6, Hot Scenery Bio announced that its two testing products independently developed have obtained relevant certifications. Among them, the monkeypox virus antigen detection kit (colloidal gold method) was certified by MHRA in Britain for the detection of monkeypox virus antigen; Novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) has been certified by CTDA in the UK, which is used for rapid and qualitative detection of novel coronavirus antigen in human nasal swab in vitro. The product can be used for self-inspection by non-professionals.

  Hot View Bio said that the monkeypox virus antigen detection kit (colloidal gold method) independently developed by the company can be sold in the UK and countries and regions that recognize the MHRA registration in the UK after being registered in the UK. The company’s novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) has obtained the British CTDA certification, and the Coronavirus Test Device Approvals (CTDA) is a regulation issued by the British government for COVID-19 detection reagents. The novel coronavirus (2019-nCoV) antigen test kit (colloidal gold method) obtained the five-year CTDA certification in the UK, which indicates that the company’s COVID-19 antigen test reagent has been fully recognized in the UK, and the authorization has been changed from emergency use to long-term certification, which will further serve the normal epidemic prevention needs in Covid-19, UK.

  Fosun Industrial Investment, the concerted action of Hainan Mining’s controlling shareholder, reduced its shareholding by 1.66%.

  () Announcement was issued. On September 6, 2022, the company received the Notice of Share Reduction from Shanghai Fosun Industrial Investment Co., Ltd. ("Fosun Investment"), the concerted action of the company’s controlling shareholder. From September 1, 2022 to September 6, 2022, Fosun Investment reduced its shareholding by 33.708 million shares, accounting for 1.66% of the company’s total share capital. As of the disclosure date of this announcement, Fosun Investment Co., Ltd. has reduced its holdings by more than half, and this reduction plan has not yet been implemented. Shanghai Fosun High-Tech (Group) Co., Ltd. is the controlling shareholder of Fosun Investment.

  Chuantou Energy: Tianwanhe Company, a subsidiary company, will conduct investigation and repair in an orderly manner without any casualties.

  Sichuan Investment Energy announced on the evening of September 6 that after the earthquake of magnitude 6.8 occurred in Luding County, Ganzi Prefecture, Sichuan Province, the company immediately launched an emergency plan and conducted a comprehensive investigation. The cascade power stations of Tianwanhe Company, a subsidiary of the company, are located in Kangding County, Ganzi Prefecture and Shimian County, Ya ‘an City, both of which belong to the Xianshuihe fault zone, and the nearest linear distance from the epicenter is only about 22 kilometers. After the earthquake, Tianwanhe Company immediately launched the first-class emergency response to emergencies, implemented scientific disaster relief to prevent secondary disasters and resumed work in an orderly manner under the condition of ensuring safety. At present, a total of 69 people have been evacuated to safety, and there are no casualties; Through Chengdu remote control production monitoring camera and on-site drone search, it is found that there are no signs of damage on the dam surface of Renzonghai Reservoir. The generator sets of Renzonghai Power Station, Jinwo Power Station and Daji Power Station were not damaged. However, due to the earthquake, the surrounding mountains and many travel sections collapsed, causing traffic disruption.

  In the next step, Tianwanhe Company will, on the premise of ensuring the safety of personnel, carry out the investigation of hidden dangers of production equipment and hydraulic structures after the earthquake, the repair of equipment and facilities, the repair and reinforcement of damaged output lines and the rush of roads in an orderly manner, and strive to achieve comprehensive resumption of production as soon as possible and restore the safe and stable operation of river basin units.

  A total of five hydropower stations in Qingyijiang, Tianquan River and Nirihe River basins, which belong to Sichuan Investment Power, a subsidiary of the company, are all about 100 kilometers away from the epicenter, and the earthquake was obvious at the scene. After the earthquake, each power station immediately entered an emergency state and launched emergency plans for emergencies and earthquakes, and conducted hidden dangers investigation on important points such as main power houses, unit equipment, dams and transmission lines. At present, the equipment of each power station is in good working condition, running safely and stably, and is doing its best to ensure power supply.

  After on-site emergency safety inspection, the earthquake did not affect and lose the construction of Panzhihua hydropower project, a subsidiary of the company, and the project safety was under control, and the project construction quickly returned to normal order.

  Shimao Energy will send 2 yuan date of record for every 10 shares in the first half of 2022 as September 14th.

  Shimao Energy announced that the company’s half-year equity distribution implementation plan for 2022 is as follows: based on the total share capital of 160 million shares, a cash dividend of RMB 2.00 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 32 million will be distributed, accounting for 33.45% of the net profit attributable to the mother in the same period. No bonus shares will be distributed and no capital reserve will be converted into share capital.

  The distribution of rights and interests in date of record is September 14th, and the ex-dividend date is September 15th.

  According to Shimao Energy’s semi-annual performance report for 2022, the company’s operating income was 201 million yuan, a year-on-year increase of 9.32%; The net profit attributable to shareholders of listed companies was 95.674 million yuan, a year-on-year increase of 14.77%; The basic earnings per share was 0.60 yuan, compared with 0.69 yuan in the same period last year.

  The main business of Ningbo Shimao Energy Co., Ltd. is to produce and sell power and steam products. The company’s main products are steam and electricity, which are energy products based on industrial enterprises. Among them, steam products are supplied to industrial enterprises in Yuyao Zhongyi Ningbo Ecological Park, electroplating park and food park around the company, and all power products are incorporated into Ningbo power grid according to the Purchase and Sale Contract signed with Ningbo Power Supply Company of State Grid Zhejiang Electric Power Co., Ltd.

  (Source: () iFinD)

  Kanglongda: It is planned to acquire 17.67% equity of Tiancheng Lithium Industry for 212 million yuan.

  () On the evening of September 6th, it was announced that the company planned to acquire 11.31% and 6.36% shares of Jiangxi Tiancheng Lithium Industry Co., Ltd. (referred to as "Tiancheng Lithium Industry") from Tiancheng Management and Yiyuan Lithium respectively for 212 million yuan, totaling 17.67% shares. After the transaction is completed, the company will hold 51% equity of Tiancheng Lithium Industry, and Tiancheng Lithium Industry will become a holding subsidiary of the company. The production line of 10,000 tons of lithium carbonate equivalent lithium sulfate solution in Tiancheng Lithium Industry has been completed, and it entered the trial production stage in May, and now it has reached the design capacity.

  Kanglongda: It is planned to acquire 17.67% equity of Jiangxi Tiancheng Lithium Industry Co., Ltd. for 212 million yuan.

  Kanglongda announced that on September 6, 2022, the company signed the Equity Transfer Agreement with Tiancheng Management, Yiyuan Lithium, Dong Aihua and Li Jinping, and planned to acquire 11.31% and 6.36% equity of Tiancheng Lithium from Tiancheng Management and Yiyuan Lithium respectively for 212 million yuan, totaling 17.67% equity. Before the completion of this transaction, Tiancheng Lithium Industry was a shareholding company holding 33.33% of the company’s shares; After the completion of this transaction, the company will hold 51.00% equity of Tiancheng Lithium Industry, and Tiancheng Lithium Industry will become a holding subsidiary of the company.

  Kanglongda intends to increase its holdings in Tiancheng Lithium Industry and its existing production line of lithium sulfate solution with 10,000 tons of lithium carbonate equivalent.

  Kanglongda announced that on September 6, 2022, the company signed the Equity Transfer Agreement with Yichun Propylene Tiancheng Management Consulting Center (Limited Partnership) ("Tiancheng Management"), Yichun Yiyuan Lithium Consulting Center (Limited Partnership) ("Yiyuan Lithium"), Dong Aihua and Li Jinping, and acquired Jiangxi Tiancheng Lithium Industry Co., Ltd. ("Tiancheng Lithium Industry") from Tiancheng Management and Yiyuan Lithium for 212 million yuan. After the completion of this transaction, the company will hold 51% equity of Tiancheng Lithium Industry, and Tiancheng Lithium Industry will become a holding subsidiary of the company.

  It is reported that Tiancheng Lithium Industry is a production enterprise specializing in refining lithium sulfate solution. In the early stage, the company acquired 33.33% equity of the target company through capital increase and equity transfer, and now it is a shareholding company. The company’s acquisition of part of the equity of the target company will help accelerate the breakthrough of the company’s existing industrial bottleneck, further expand the existing business scope and accelerate the transformation and upgrading. In addition, Tiancheng Lithium Industry’s "10,000 tons lithium carbonate equivalent lithium sulfate solution production line" has been completed, and entered the trial production stage in May, and now it has reached the design capacity.

  According to the announcement, the transaction price is 212 million yuan, and the difference between the combined cost of the acquisition and the fair value of the identifiable net assets will be recognized as goodwill, with an estimated amount of about 387 million yuan, which poses the risk of forming a large amount of goodwill.

  Taiji Group Levofloxacin and Sodium Chloride Injection Approved to Increase Specifications

  Taiji Group announced on the evening of September 6th that Southwest Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received the Notice of Approval for Drug Supplement Application from National Medical Products Administration, agreeing to increase the specifications of its "levofloxacin sodium chloride injection (class 4 of chemicals)" by 50ml: levofloxacin 0.25g and sodium chloride 0.45g, and issued the approval number. It is reported that the company obtained the drug registration certificate in April 2021, and the specifications approved at that time were 100ml: levofloxacin 0.5g and sodium chloride 0.9 g; On June 23 of the same year, the company won the bid for the fifth batch of national centralized collection of this drug.

  According to the data, the indications of levofloxacin sodium chloride injection are mainly used to treat the following mild, moderate and severe infections caused by sensitive strains such as Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Enterococcus faecalis or methicillin-sensitive Staphylococcus epidermidis in adults over 18 years old: Hospital-acquired pneumonia; Community acquired pneumonia; Acute bacterial sinusitis; Acute bacterial attack of chronic bronchitis; Complex skin and skin structure infection; Non-complex skin and skin soft tissue infection; Chronic bacterial prostatitis; Complex urinary tract infection; Acute pyelonephritis; Non-complex urinary tract infection; Treatment of inhaled anthrax (after exposure).

  This drug is a Class B drug in the Catalogue of National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2020 Edition). Up to now, according to the query of National Medical Products Administration database, there are 6 domestic companies with the production approval documents of this specification, and Southwest Pharmaceutical Co., Ltd. has obtained the production approval documents of this specification for the sixth company. According to the statistics of "Menet" database, in 2021, the total sales volume of levofloxacin sodium chloride injection with 50ml specifications in China city public hospitals was about 10.96 million yuan.

  Taiji Group said that according to the relevant national policies, the increased specifications of the drug are consistent with the quality and efficacy of the original drug, and the approval of listing is regarded as a consistent evaluation of the quality and efficacy of generic drugs, which is conducive to enhancing the market competitiveness of the drug.

Lexus RX price reduction news in Guangzhou, discount 10,000! Plenty of cars

Welcome to [Autohome Guangzhou Discount Promotion Channel], we bring you the latest promotion information of the model. At present, the Lexus RX in Guangzhou is undergoing an unprecedented price reduction activity, with the highest discount reaching an astonishing 10,000 yuan, making the luxury SUV originally priced at 395,000 yuan to reach a more attractive price point. If you are interested in the Lexus RX, don’t miss this rare opportunity. Click "Check the car price" in the quotation form now, and let us help you get the most accurate discount details and car purchase suggestions to seize this rare car purchase opportunity.

广州地区雷克萨斯RX降价消息,优惠1万!现车充足

The exterior design of the Lexus RX fuses elegance and power, revealing the brand’s unique luxury temperament. The front face is sharply designed, with a family-style spindle-shaped air intake grille and LED headlight sets, giving the vehicle a striking recognition. The overall style is smooth and sporty, with clear lines, creating a strong dynamic beauty. The side profile of the body is full, highlighting the stability and power of a premium SUV. Whether it is the details or the overall shape, the Lexus RX fully demonstrates its exquisite craftsmanship and excellent design concept.

广州地区雷克萨斯RX降价消息,优惠1万!现车充足

The Lexus RX is elegant with its refined side design. The body size is 4890mm*1920mm*1695mm and the wheelbase reaches 2850mm, ensuring a large interior space and good driving stability. The side lines are smooth and full of power, and the 235/60 R19 size tires provide excellent driving performance and visual effect. The choice of tires focuses on comfort and grip, while the wheel design continues the luxury of the Lexus brand.

广州地区雷克萨斯RX降价消息,优惠1万!现车充足

The interior design of the Lexus RX is designed with attention to detail and luxury, showing the exquisite quality unique to the brand. The steering wheel is made of genuine leather, which feels comfortable to hold and supports electric up, down and front and rear adjustment to ensure the best operating experience for the driver. The central control area is equipped with a 9.8-inch touch screen, which is clear and easy to use. It integrates functions such as multimedia system, navigation, phone and air conditioning, and supports automatic speech recognition control, which enhances the convenience of the driving process.

In terms of seats, both the main driver and the co-pilot are made of imitation leather, providing front and rear, backrest, high and low multi-directional adjustment functions, including waist support, to ensure passenger comfort. The second row of seats also supports backrest adjustment, while the rear seats support proportional reclining, providing passengers with flexible space layout and storage options. The overall interior design combines practicality and luxury, fully reflecting the interior highlights of the Lexus RX.

广州地区雷克萨斯RX降价消息,优惠1万!现车充足

The Lexus RX is equipped with a 2.5L four-cylinder engine capable of delivering a maximum power of 139 kilowatts and a peak torque of 241 Nm. This powertrain uses an E-CVT continuously variable transmission, providing a smooth driving experience and good fuel economy.

Overall, Autohome owners are full of praise for the appearance of the Lexus RX, believing that it shows the perfect combination of luxury and stability. The unique front face design and elegant body lines make it stand out in traffic and attract attention. For drivers who pursue individuality and quality, the Lexus RX is undoubtedly a highly recognizable choice.

Every festival is a cultural feast.

□ Qin Yanan

Festivals are a kind of folk culture created by people all over the world to meet the needs of production and life, and are an important part of the world folk culture. Every traditional festival in China has poems to sing and recite. Festival poetry is an expression of China traditional literati’s poetic life. At the age of 20, the season triggered the poet’s emotional gate, and put reason into poetry, expressing feelings through poetry.

Without culture, it seems that there is only food in the festival. Dragon Boat Festival, eat zongzi; Mid-Autumn Festival, eat moon cakes; Lantern Festival, eating Lantern Festival … With culture, the Dragon Boat Festival has the patriotic spirit of "racing for a thousand years, and the loyal soul can be returned when it is gone" (Northern Song Dynasty Zhang Lei’s "Dragon Boat Festival"); The Mid-Autumn Festival has a love blessing of "I wish people a long time and a thousand miles together" (Su Shi’s Mid-Autumn Festival by Bingchen); On the Lantern Festival, there will be the prosperity of "Thousands of doors unlock and thousands of lights shine, and in the middle of the first month, the Imperial Capital will be moved" (Tang Zhang’s "Night Lights on the 15th of the First Month") … China Festival, accompanied by China’s poems, is full of 5,000 years of civilization.

Chen Shuqian, a master tutor and scholar in the College of Literature of Heilongjiang University who is committed to promoting China’s excellent traditional culture, in his new book "Poetry Feast in Festivals", takes China’s traditional festivals as the classics and ancient classical poems as the latitude, rambles about the vicissitudes of ancient and modern personnel, allowing readers to follow the gentle and graceful trajectory of classical poems, walk into the gardens of China’s traditional culture, and feel the smell of fireworks and the beauty of prosperity in China’s traditional festivals.

As a compilation of ancient poems of traditional festivals in China, the book is arranged in the chronological order of 16 traditional festivals, including Yuanri, Renri, Yuanxiao, beginning of spring, Huachao, Shangsi, Cold Food, Qingming, Dragon Boat Festival, Tanabata, Zhongyuan, Mid-Autumn Festival, Chongyang, Winter Solstice, Laba and New Year’s Eve, and selects 276 famous works that can reflect distinctive holiday characteristics from the Book of Songs to the Qing Dynasty for more than two thousand years. The lyrics of poems under each festival are arranged in the order of four-character, five-character, seven-character poems, words and songs. In the content, it is divided into comments (or explanations), notes and comments, and related links are noted in chronological order, telling the origin, implication, development and changes of festivals, the festival customs from the Imperial Palace to the market, and the development and changes of customs in different dynasties, which is of great ideological, artistic and inheritance.

Traditional festivals are precious legacies left by ancestors. Each festival has mysterious legends and specific customs, and each festival has been endowed with unique emotional memories and profound cultural connotations by poets. For example, in the Yuan Dynasty, which originated from the Han Dynasty, there were customs such as eating rice cakes, pasting peach symbols and setting off firecrackers. In the Northern Song Dynasty, Wang Anshi’s "Thousands of families always change new peaches for old symbols" made thousands of families happy for the Spring Festival. For example, it is said that there are customs such as cutting ribbons and making smoked cakes on Nu Wa’s creation day. Xue Daoheng, a poet in the Northern and Southern Dynasties, wrote that "after a person falls into a wild goose, he thinks before a flower", which makes the wanderer’s infinite melancholy of homesickness come to life … From traditional festivals, he excavates relevant folk allusions, captures folk customs and seasonal elegance, shares the true lifestyle, and writes the wisdom and beauty of festival cultural inheritance, which not only entrusts the cultural feelings of the descendants of the Chinese people, but also epitomizes the mature civilization of a nation.

Ordinary secular life, with lively festivals, constitutes a complete life time for ordinary people in China, which makes life extraordinary because it is full of expectation and pleasure. For example, "beginning of spring whips cattle", "Spring outing in Qingming Festival", "Laba gives porridge" and "Winter Solstice Worship", etc., festivals are covered with bright coats, which show a touch of novelty in the dull and boring life. "Under the guidance of generations of China people, they show harmonious and harmonious aesthetic taste, the philosophy of harmony between man and nature, and the balance of yin and yang", which edifies people’s diet, manners and customs. "Life is dying with the years, and the body is forgotten; No complex Tu Su Meng, burning the lamp night is still young "(Wen Tianxiang’s" Except Night "). Facing the last New Year’s Eve of life, the poet is fearless, and only wants to get together with his family to make a toast. This kind of "fragility" which is sprouted because of family ties is even more gentle and majestic … Festival poems, life scrolls, and deep feelings not only reflect the meaning of "civilization stops and turns into the world", but also infiltrate the muscles and bones of the Chinese nation.

Every festival is a cultural feast. This book not only allows us to find a way out in the feast of festival culture, but also finds a way out in protecting the ecological environment of folk culture.

Keji

Insurance technology products are listed together.

2017 can be said to be a year of insurance technology in generate. Unlike the previous tinkering with face recognition insurance, many insurance companies began to list insurance technology as their development strategy. Insurance companies and internet giants have demonstrated their scientific and technological strength, or applied blockchain technology, or launched AI (artificial intelligence) products, and opened relevant platforms to the industry. "Technology+Insurance" is transitioning from concept to application, and the impact of technology on the insurance industry has really begun.

For example, China Pacific Insurance put forward the strategy of "Digital Pacific Insurance" this year, and recently it made a high-profile appearance with the smart insurance product "Alpha Insurance". China Ping An also recently released "smart insurance cloud" products, including "smart authentication" and "smart flash compensation". The same market participants are Ant Financial. In the first half of this year, Ant Financial successively launched products such as "auto insurance" and "fixed loss treasure". Some internet insurance companies, such as Zhongan Insurance, and insurance sales companies have also launched insurance technology products such as big health and smart investment.

Consumers always think that insurance products are far away from themselves, and the emergence of insurance technology will make products suitable for more scenarios. At present, the insurance market is facing great user demand, but some insurance companies and platforms have valuable user resources, but they have failed to meet the needs of users successfully, and lack the mechanism and system of activation, retention and transformation. How to connect users’ needs and insurance ability, the role of insurance technology is essential.

Sikao

Enter the tuyere or fall into the bubble?

According to the industry forecast, the insurance technology market has great potential and will reach 2.4 trillion by 2021. For this reason, traditional insurance companies and internet companies are actively moving closer to insurance technology, trying to share the pie.

Zhongan Insurance, the first Internet insurance company in China jointly established by Alibaba, Tencent and Ping An Insurance, has been called the "first share" of insurance technology by the industry. At present, the insurance industry pays more and more attention to technology research and development, and the landing and application of insurance technology are also increasing. Does insurance technology enter the market or fall into the bubble? Many people in the industry said that the current development of insurance technology is somewhat blind, many of which are the products of a momentary fever, and many technical things are aimed at auto insurance, but insurance companies are not aware of it. In addition, insurance technology products such as smart investment and care are of little significance unless they can really evaluate and guide family wealth and family health.

The focus of insurance technology is how to better meet the needs of users. In China, many people don’t know enough about insurance, and they don’t agree with its cost performance and other aspects. The emergence of insurance technology enables the industry to "educate" the insurance market by means of science and technology, to do things that benefit and educate users through science and technology, and gradually let consumers accept insurance.

It should be reminded that with the continuous penetration of new technologies into the insurance industry, almost all insurance production links, including product design, pricing, sales and claims settlement, are being reshaped. The existing regulatory framework is based on the traditional operation mode, which is not suitable for insurance technology to some extent, and it is still blank in some fields, and it is urgent to speed up the research on regulatory policies and improve rules.

Interview with Director Zheng Xiaolong | Creation should tell the story of "people"

The closing battle report of TV series The Story of Xingfu came one after another. After Empresses in the Palace, who has been tossed and turned for 11 years, Zheng Xiaolong brought an excellent work with both reputation and popularity.

Few directors can expand the audience to all ages like Zheng Xiaolong, so that groups of different generations can find sympathetic emotions and characters in his works. Similarly, few directors can make their works last forever, constantly adding new audiences to the original basic disc, and their works are always new, always keeping the pulse and temperature of the same rhythm with the times.

Zheng Xiaolong, born in 1953, has been directing since the early 1990s. His works in different periods, such as Peking Man in new york, Golden Wedding, Empresses in the Palace, legend of miyue, Red Sorghum, Emergency Doctor, Meritorious Service, etc., have almost covered audiences after 60, 70, 80, 90 and 00, and he is a well-deserved national director. At the same time, he is also a literary and art worker who is very concerned about how individuals survive in the changes of the times. Under the focus of the camera, they are all concrete "people", and the "play meat" filled in the drama framework is also concrete and subtle details. He always believes in a foothold. "Emotion and truth are common, and I mainly tell the story of’ people’."

01

The Story of Xingfu: Dead Water and Breaking.

The realistic TV series The Story of Xingfu, directed by Zheng Xiaolong and starring Zhao Liying and Liu Wei, has closed recently. As a long-lost rural theme work in the domestic drama market, the first broadcast of the drama set off a viewing craze. The prime-time TV live broadcast attracted the top two attention, and the online broadcast was less than an hour. The market share of the whole network drama reached the top, and the real-time broadcast market accounted for 11.46%. At the same time, because of the portrayal of realistic contradictions and the exposure of human weaknesses, it has repeatedly caused heated discussions on social platforms such as Weibo. In the whole broadcast process in The Story of Xingfu, it occupied the top spot in the lighthouse TV drama feature broadcast market for 22 consecutive days, and ranked third in the 2022 TV drama feature broadcast before closing. These steady and steady data all show the amazing national popularity of this work.

The Story of Xingfu was adapted from Chen Yuanbin’s novel The Legend of Autumn Chrysanthemum. At the beginning, Zheng Xiaolong took a fancy to this story. "It mainly tells the awakening of a woman’s self-awareness and legal awareness. Under the environment of emphasizing the rule of law, literary and artistic creation is of certain significance to the construction of the awareness of the rule of law. I think it is very good." Wanjiazhuang, as a famous star village with ten miles and eight townships, has reached a certain level in material accumulation. However, due to its inherent small-scale peasant ideology and clan consciousness, this village has become a "stagnant water" and gradually has the trend of "one word at a time". "So the theme of our story is to hope that people will pay more attention to the construction of spiritual civilization and legal civilization after the completion of material civilization construction. Because there is no progress in spiritual civilization and the rule of law, this’ rich’ will not grow. "

And the heroine’s happiness is the "breaker" of Wanjiazhuang’s stagnant water.

In the initial casting stage, Zheng Xiaolong decided to let Zhao Liying play He Happiness. "We worked together in the filming of Golden Wedding in 2006, and she played many rebellious third daughters in it. She was so stubborn. Moreover, she is born in the countryside and is no stranger to rural life and the state of farmers. "

Zheng Xiaolong believes that the character He Happiness comes with a "halo". Of course, "halo" is not an illogical protagonist halo, but "He Happiness has a basic personality, and she has a simple sense of justice, fairness and equality." As a rural woman with a low education level, she was so happy that her sister was married. She insisted on an apology and was pointed at by the villagers. However, Wanjiazhuang, whose clan consciousness is solidified, needs such a foreigner to break the deadlock. "Because she doesn’t understand the process of the village construction and the prestige of Wanshantang, the village party secretary, she just thinks that I can apologize if I am wrong, but you have to admit it if you are wrong. You have to apologize."

He Xingfu threw a bench over and smashed the head of Wan Chuanjia, the son of the village party secretary, which prevented the marriage and caused trouble. His in-laws were anxious to apologize to the village party secretary, and her husband, brother-in-law and sister-in-law were also wronged and anxious. On the other hand, Zheng Xiaolong used a series of long shots to show the attitude of He Happiness as a new wife. She changed her clothes, tied up her long hair, skillfully picked vegetables, and packed things for cooking. When her husband questioned that she was still in the mood to eat, her attitude was also obvious: the sky fell and she had to eat, and then she went to seek justice after eating.

"Maybe the audience will be more worried about saying that female stars or famous actresses can’t get down and dress up ugly, but in reality, it can’t be glamorous. You work in the countryside and your daughter-in-law is running a family. You have to be energetic, right?" Zheng Xiaolong admired Zhao Liying’s energy. "If she didn’t understand it, she couldn’t shoot it. She didn’t rely on skill, but brought her true nature in, so you will feel particularly comfortable when she performs."

Since the launch of The Story of Xingfu, many viewers’ comments and barrage have been related to "grieve" and "bring your own antihypertensive drugs when watching the drama". The initial marriage-making incidents, land disputes and compensation for land expropriation, including the protagonist’s experience from rural to urban, are all full of realistic entanglements. The material construction of Wanjiazhuang Star Village is indeed rich enough, but the popularization of rule of law awareness and spiritual civilization construction seems to be uncivilized. The main line of the story is how to build the rule of law on the basis of material construction. Happiness is the main thread of this torrent, and her personal progress and growth is also a metaphor for the follow-up of rural spiritual civilization and the rule of law. The anger of netizens, to a certain extent, is also an affirmation that the content of the series is close to real life. Zheng Xiaolong also recognized this point. "We must conform to this creative attitude of realism. Now telling rural stories is to conform to the changes and cognition in the countryside and have a life atmosphere."

At the end of the story, He Xingfu promoted the construction of ecological civilization in Wanjiazhuang, developed environmental protection tourism industry, controlled sewage treatment, broke the original clan pattern, popularized the concept of legal system, and became a new generation of rural revitalization leaders. Behind the destruction of this stagnant pool is not only Zheng Xiaolong’s thinking about the current rural spiritual civilization and legal system construction, but also his inherent sense of responsibility as a literary and art worker. "Creating this thing makes me feel that I can say something and express something that I think is meaningful." He wants to tell the story of a rural woman’s growth, and reflect the fate and struggle of thousands of ordinary people in Qian Qian. This concern and gaze on the little people has always been a humanistic feeling of Zheng Xiaolong’s social responsibility.

02

"Feminine consciousness" not only represents women.

The Story of Xingfu has been at the forefront from the beginning to the end, and the whole network urged him to get a happy divorce and start a career. In addition to the characters and plots in the play, there is also director Zheng Xiaolong who was brought to the hot search by real-time comments.

In fact, it’s not long since he was widely discussed by netizens and audiences last time-during the period when the epidemic was banned at the beginning of the year, Empresses in the Palace became a drama and background sound for many people. Since its launch 11 years ago, the ideological trend has changed, the concept has been updated, and the audience has iterated. However, the popularity and discussion of this drama have lasted for a long time. Under the "study" of the younger generation of netizens, an independent "Zhen Xue" has even been derived, which is specially used to analyze characters, plots and subtle scenes, including the production of expression packs and network hotspots.

However, in the eyes of Zheng Xiaolong, who is nearly 70 years old, these new things and fragmented interception analysis are all "distant" and he doesn’t understand them. In the 22nd year of the new century, he still maintains his own work rhythm and relatively "old-school" habits. Only when talking about creation will the chatterbox open, "What are the 100 questions? I can’t even answer it. TV plays and movies are montage art, and they are flowing pictures, not watched frame by frame. When I shoot, I will not think that this drama will have such a big impact in reality. "

From Empresses in the Palace’s "Red Sorghum" and "legend of miyue" to The Story of Xingfu, several representative works of Zheng Xiaolong are all based on the clue of women’s growth and awakening, and are completed by the whole construction of the characters, so as to criticize and convey his inner thoughts and voices. However, the growth of women, or the awakening of gender-limited consciousness, is not that he deliberately caters to the creative standards of the market. Instead of telling the story with a specific group, he chose a reference sample to tell the story of everyone in the society, age and living environment where the sample is located. "Emotion and reason are common, and I mainly tell the story of’ people’."

Empresses in the Palace stills

For example, Empresses in the Palace criticized the feudal and backward marriage system. Zheng Xiaolong said, "I discussed this matter repeatedly before filming, and I told the media that it was critical. But after it was broadcast, many people said that it was a matter of the workplace. I was so dizzy. I never thought that the workplace would be like this." He recalled that mentality more than ten years ago. "At that time, for a long time, it seemed that everyone thought the harem was beautiful and luxurious. Many girls wanted to cross into the harem and run to be concubines for the emperor." "The emperor is a big stallion, marriage in this case, how can you have a single-minded emotion? Impossible. "

The realistic theme does not mean that you must shoot modern dramas, which is also Zheng Xiaolong’s consistent thinking. "You can also shoot historical stories with a realistic attitude. The theme and your attitude are two different things." What Empresses in the Palace conveyed was his criticism of the feudal and backward marriage system, while legend of miyue is another kind of realism-historical materialism, which contains the awakening of women, the germination of the consciousness of family and country and the concept of equality. "Miyue is a concubine of Chu. She gradually developed a sense of home and country around the king of Qin, and she also had a critical awareness of the hierarchical bloodline theory and hereditary system, so she would take risks and return to Qin to pacify civil strife and lay the foundation for Qin Shihuang to unify China. Including the Qin Dynasty’s award for military merits, rather than hereditary, these are also the seeds of equality. "

"legend of miyue" stills

He doesn’t think it is necessary to convey specific ideas through specific themes, and there is no need to limit the gender or identity background of the protagonist. "In fact, people who engage in literary and artistic creation do image, and there is a saying that image is greater than thinking." Zheng Xiaolong is a person who came from the initial period of China TV series, and his attitude is still simple and plain. "After you have done your image well, many people will give it something to think about. For example, when Cao Xueqin wrote A Dream of Red Mansions, he didn’t think so much, he just truly reflected the society. Later, Comrade Mao Zedong said that A Dream of Red Mansions was a mirror of feudal society, and it became a mirror of feudal society, which was the understanding given by later generations. A lot of thinking things don’t mean that we have thought it through in the early stage of creation. We just do a good job in the image. As for the interpretation, how big the subsequent impact is, this is not something that can be thought of at the beginning. "

After being created, the female images in Zheng Xiaolong’s works began to have a lot of interpretations, some of which were even quite different from his original creative ideas, which he had never expected in his creation. However, whatever Zhen Xuan, Mi Yue or happiness, behind their awakening of female consciousness and independent consciousness is actually the awakening of human nature-an awakening of equality, struggle and the rule of law. This has nothing to do with gender, but belongs to everyone’s right consciousness. There’s a line in The Story of Xingfu, which Zheng Xiaolong especially picked out and spoke it again. "Distinguish right from wrong through law, clarify truth through law, and popularize social fairness and justice through law. I think it is very important, because we want to build a society ruled by law. This is also what I want to convey through this drama. "

As for the arguments, contradictions and conflicts intercepted by the fragments, and the remarks urging a happy divorce, they all belong to the endowed "thinking", which is the part that literary and artistic creators can’t control after the completion of their works. Zheng Xiaolong tried to digest the gap between himself and the young audience. "I think literary works still need a little nutrition, and there must be emotional things in them. If the general direction is right, you can."

03

The significance of realism

After decades of film and television drama, Zheng Xiaolong, which has become a benchmark in the industry, has maintained a stable output, but it is not a "high yield". For the production and polishing of the script, including the preparation before starting, he has to spend a lot of thought and effort to dig the details. Even at this age, the vitality of creation and strong desire for expression are still shining on him.

The Story of Xingfu finalized Zhao Liying, and it also experienced some twists and turns in the middle. Because the actor was pregnant and the script was revised, it was almost more than a year before and after. "After the script was revised, the actor also gave birth to the child and sat down for a month. This is settled."

In the era of fast food, Zheng Xiaolong’s process of polishing the script and preparing the details can be said to be very "burning money". "I have to collect ideas and make field trips. I am particularly concerned about this matter and go to see Anhui local Huizhou architecture. For example, when drilling a well, I have to ask if there was such a photo at that time. The arrangement of the wedding venue for the couple, were they like this at that time? Is the construction of rural houses like this? Moreover, I have to ask the original owner (many details), because a lot of the photos we took are real scenes, and the interior is also real scenes. I am afraid that the art will be wrong. "

At the beginning, in the interview during the broadcast of Golden Wedding, Zheng Xiaolong also mentioned the "obsession" of scene restoration. After the script was polished, it was the preparation of the group, from a food stamp to a bus, which was arranged exactly according to the set points of that era. "Realism" is the key point he has always stressed. Only when the literary image reaches a certain level can the audience’s thinking be attached. "As long as you make a good image, it will have an impact on reality. As long as you make it true and reasonable, it will have an impact on reality."

Stills of "Golden Wedding"

"Influence on reality" is the sense of social responsibility that Zheng Xiaolong’s generation of literary and art workers insisted on. When a work is filmed, it is not just for fun, but for the audience to laugh. It has to be meaningful and effective in reality. As for how long and how wide this role can be played, it is uncontrollable, but at the very least, it must have a little effect.

Even now, there are some records of old reports in the evaluation of Zheng Xiaolong by Zhihu and other platforms: "The broadcast of" Desire "triggered an unprecedented upsurge of national audiences, and actors such as Li Xuejian, Zhang Kaili and Huang Meiying also became popular throughout the country. At that time, in order to watch "Desire", people with TV sets were crowded into the station almost every day. Even the Ministry of Public Security said that thieves did not come out to commit crimes because they were waiting to watch "Desire". "

Zheng Xiaolong couldn’t help laughing when he mentioned these sensational influences. This is the pride of literary and art workers and the great affirmation of a director who has devoted his life to it.

Speaking of Empresses in the Palace’s overseas export and cultural communication, Zheng Xiaolong once again emphasized the importance of realism. "Truthfulness, telling a good story about China’s history, telling a good story about China now and telling a good story about the daily life of China people, I think this is all possible. In particular, telling the story of the daily life of ordinary people must be authentic and have universal typical significance. "

Of course, we also asked Zheng Xiaolong what he thought of the current shoddy and suspended film and television dramas. He replied very quickly, "I don’t watch it. I don’t think it looks good. I don’t watch it. I can’t watch it, and I’m not affected."

This national director, who is nearly 70 years old, just wants to tell his own story-a story about every specific "person".

Written by Gu Xiang

— THE